C anc er_ is _ a_ gro up _of_ diseas es _ inv ol vi ng _ ab no r ma l _cell_ growth_ with _ the_ po te n t ia l _ to _ inv ad e_ or_ s pr e ad _ to _ ot he r _ pa r t s_of_ the_ bo d y. _ Th ese_ co n tr as t_ with _ be n ig n_ tumor s,_which_ do _ not_ s pr e ad ._P os sib le _ sign s_and_ symp to m s_ of _can c er_ include _ a_ lu mp ,_ ab no r ma l _ bl e ed ing,_ pr olon g ed _c oug h ,_ un ex pla in ed _ we ight_ los s,_ and_ a_ ch ang e_ in_ bo we l _m ov em ent s. _ Wh ile_ these_ symp to m s_ may_ indi c ate_ c anc er,_ they_ c an_ also_ have_ ot he r _caus es._ O ve r _ 10 0_ typ es _ of _can c ers_ affect _ hum an s.
A bo ut _ 3 3 %_of _ de at h s_ fr om _can c er_ are_ caus ed _ by_ tob ac co _and_ al co ho l _con su mp tion ,_ ob es it y, _ l ac k_ of_ fr u it _and_ ve get ab le s_in_ di et _and_ l ac k_ of_ ex er c is e. _ O ther_ fac to r s_ include _certa in_ infection s,_ expo su re _ to _ ionizing_ radi ation ,_and_ en vi ro n me n ta l _ po l lu ta n t s. _ In fect ion_ with _ spec ific _ vi r us es,_ b ac te r ia ,_and_ pa ra sit es _caus es _ ap pr ox im ately_ 16 – 1 8 %_of _can c ers_ world wi de ._These_ infect ious_ agent s_ include _ H el ic ob ac te r _ p yl or i ,_ he pa t it is _ B ,_ he pa t it is _ C ,_ H P V ,_ Ep st e in – B arr _ vi r us,_ H um an_ T - lymp ho tr op ic_ vi r us _ 1 ,_ K ap os i 's_ s ar co ma - ass oc ia te d_ he r pe s vi r us _and_ M er k el _cell_ po ly om av ir us ._H um an_ im mu no def ici enc y_ vi r us _ ( H I V )_ do es _ not_ di rect ly _caus e_c anc er,_ but_ it _caus es _ im mu ne _ def ici enc y_ that _can _ in cr e as e_the_ ris k_ of _can c er_ fr om _ ot he r _ infection s,_ som et im es _ up _ to _ se ve ra l _ th ou s and fol d_ ( in_the_ c as e_of_ K ap os i 's_ s ar co ma ) ._I mp or ta n t ly ,_ v acc in ation_ again st_ the_ he pa t it is _ B _ vi r us _and_ the_ hum an_ pa p il lo ma vi r us _ have_been_ sh ow n_ to _ ne ar ly _ el im in ate_ the_ ris k_ of _can c ers_ caus ed _ by_ these_ vi r us es _ in_ pe r s on s_ su cc ess ful ly _ v acc in at ed _ pr i or_ to _ infection .
Th ese_ en vi ro n me n ta l _ fac to r s_ ac t ,_ at_ le as t_ pa r t ly ,_ by_ ch ang ing_the_ gen es _of_ a_ c ell ._T yp ical ly ,_ ma n y_ gen etic _ch ang es _ are_ requ ir ed _ be for e_c anc er_ de ve lo p s. _ A p pr ox im ately_ 5 – 10 %_of _can c ers_ are_ du e_ to _ in he r it ed _ gen etic _ defect s. _ Cancer _can _ be _ de te ct ed _ by_ c erta in_ sign s_and_ symp to m s_or_ screening_ te st s. _ I t_ is _ th en_ typ ical ly _ f ur ther_ in ve st ig at ed _ by_ me di c al_ im aging_ and_ co n fir me d_ by_ bi op sy .
The_ ris k_ of_ de ve lo p ing _certa in _can c ers_ c an_ be _ reduc ed _ by_ not_ smo kin g ,_ ma in ta in ing_ a_ health y_ we ight ,_ li m it ing_ al co ho l _ in ta k e,_ e ating_ pl ent y_of_ ve get ab le s,_ fr u it s,_ and_ wh ol e_ g ra in s,_ v acc in ation_ again st _certa in_ infect ious_ diseas es,_ li m it ing _con su mp tion _of_ pr oc es se d_ me at_ and_ red_ me at ,_and_ li m it ing_ expo su re _ to _ di rect _ su n li g h t ._E ar ly _ de te ct ion_ through_ screening_ is _ us ef ul _ for _c er vi c al_ and_ co lo rect al _can c er ._The_ be ne f its_ of_ screening_ for _ bre as t_ c anc er_ are_ co n tr over s ia l ._C anc er_ is _ of te n_ tr e at ed _ with _ som e_ co m bi n ation _of_ radiation_ therap y, _ surger y, _c he mo therap y_and_ ta r get ed _ therap y. _ M ore_ pe r s on al iz ed _ therap i es _ that _ har ne s s_ a_ pa t i ent 's_ im mu ne _ system _ are_ em erg ing_ in_the_ f i el d_ of _can c er_ im mu no therap y. _ P al li ative_c are_ is _ a_ me di c al_ spec ia l t y_ that _ de li ve r s_ advanc ed _ pa in_ and_ symp to m _m an ag em ent ,_wh ic h_ may_ be _ pa r t icul ar ly _ im po r ta n t_ in_ those_ with _ advanc ed _ diseas e. ._The_ ch anc e_of_ sur vi v al_ de pe n d s_ on_the_ typ e_ of _can c er_ and_ ex te n t_of_ disease_ at_ the_ st ar t_of_ tr e at me n t ._ In _chil dr en_ un de r _ 1 5_ at_ diagnos is,_ the_ f iv e- year _ sur vi v al_ ra te _ in_the_ de ve lo pe d_ wor ld_ is _ on_ av er age_ 8 0 % ._F or _can c er_ in_the_ Un it ed _ St at es,_ the_ av er age_ f iv e- year _ sur vi v al_ ra te _ is _ 6 6 %_ for _ all_ ag es.
In _ 201 5 ,_ about_ 9 0 . 5_ m il li on_ peop le _ world wi de _ h ad _can c er ._ In _ 20 19 ,_ an n u al _can c er _cas es _ g re w_ by_ 2 3 . 6 _m il li on_ peop le ,_and_ there_ we re _ 10 _m il li on_ de at h s_ world wi de ,_ re pr es ent ing_ over _ the_ pr ev ious_ dec ad e_ in cr e as es _of_ 2 6 %_ and_ 2 1 % ,_ res pe ct iv el y.
The_ most _com mo n_ typ es _ of _can c er_ in _m al es _ are_ lung _can c er,_ pr os ta te _can c er,_ co lo rect al _can c er,_ and_ st om ach_ cancer ._ In _ fe ma le s,_ the_ most _com mo n_ typ es _ are_ bre as t_ c anc er,_ co lo rect al _can c er,_ lung _can c er,_ and_c er vi c al _can c er ._I f_ skin _can c er_ ot he r _ th an _m el an oma_ we re _ include d_ in_ to ta l _ ne w_ cancer _cas es _ e ach_ year ,_ it _ would_ ac co un t_ for _ around_ 4 0 %_of _cas es._ In _chil dr en ,_ ac ut e_ lymp ho bl as t ic_ leuk em ia _and_ bra in_ tum ors_ are_ most _com mo n ,_ exc ep t_ in_ A fr ic a ,_wh ere_ no n - H od g kin _ lymp ho ma _ occur s_ mo re _ of te n ._ In _ 201 2 ,_ about_ 16 5 ,00 0_ ch il dr en_ un de r _ 1 5_ year s_of_ age_ we re _ diag no se d_ with _can c er ._The_ ris k_ of _can c er_ in cr e as es _ sign ific ant ly _ with _ ag e,_ and_ ma n y_ c anc ers_ occur _m ore_ co m mo n ly _ in_ de ve lo pe d_ co un tr i es._ Ra te s_are_ in cr e as ing_ as _m ore_ peop le _ li ve _ to _ an_ ol d_ age_ and_ as _ life st yl e_ ch ang es _ occur_ in_the_ de ve lo p ing_ world ._The_ g lo b al_ to ta l _ e co no mic _c os t s_ of _can c er_ we re _ es tim at ed _ at_ US $ 1. 16 _ tr il li on_ ( e qu iv al ent_ to _ $ 1. 6 7 _ tr il li on_ in_ 20 2 4 )_ pe r _ year _ as _of_ 20 10 .

E t y mo lo g y_and_ def init ion s
The_ wor d_ co me s_ fr om _ the_ anc i ent_ G re e k_ κ α ρ κ ί ν ο ς ,_ me an ing_ ' cr ab ' _and_ ' tumor ' ._ G re e k_ phys ic ia n s_ H ip po cr at es _and_ G al en ,_ am ong_ ot he r s,_ no te d_ the_s imil ar ity_ of _c ra b s_ to _ som e_ tum ors_ with _ s w ol le n_ ve in s. _ The_ wor d_ w as _ in tr od u c ed _ in_ E ng li sh _ in_the_ mo de r n_ me di c al_ se n se _ around_ 16 00 .
C anc ers_ co mp ris e_ a_ lar g e_ f am ily_ of_ diseas es _ that _ inv ol ve _ ab no r ma l _cell_ growth_ with _ the_ po te n t ia l _ to _ inv ad e_ or_ s pr e ad _ to _ ot he r _ pa r t s_of_ the_ bo d y. _ Th e y_ for m _ a_ sub se t_of_ ne op l as m s. _ A_ ne op l as m _or_ tumor_ is _ a_ gro up _ of _cells_ that _ have_ un de r g one_ un reg ul at ed _ growth_ and_ wi l l _ of te n_ for m _ a_ ma s s_or_ lu mp ,_but_ may_ be _ di str ibut ed _ diff us el y.
A l l _ tumor _cells_ sh ow _ the_s ix _ h all ma r k s_ of _can c er ._These_ ch ar ac te ris t ic s_are_ requ ir ed _ to _ pr od u c e_ a_ ma li gn ant_ tumor ._Th e y_ include:

C ell_ growth_ and_ di vi s ion_ ab se n t_ the_ pr op er_ sign als
C on t in u ous_ growth_ and_ di vi s ion_ ev en_ g iv en _con tr ary_ sign als
A v o id anc e_of_ pr o g ra m me d_ c ell_ de at h
L im it le s s_ n um be r _ of _cell_ di vi s ion s
P ro mo t ing_ bl o od _ ve s se l _con str u ct ion
In v as ion_ of_ tissu e_and_ for ma tion _ of _m et as ta se s
The_ pr o g ress ion_ fr om _ no r ma l _cells_ to _cells_ that _can _ for m _ a_ de te ct ab le _m ass_ to _can c er_ inv ol ve s_ mu l t ip le _ st ep s_ known_ as _m al ign ant_ pr o g ress ion .

S ign s_and_ symp to m s
Wh en _can c er_ be g in s,_ it _ pr od u c es _ no _ symp to m s. _ S ign s_and_ symp to m s_ appe ar_ as _ the_ ma s s_ grow s_or_ ul c er at es._ The_ f indi ng s_ that _ resul t_ de pe n d_ on _can c er 's_ typ e_and_ loc ation ._F e w_ symp to m s_are_ spec ific ._M any_ fr e qu ent ly _ occur_ in_ indi vidu al s_ who_ have_ ot he r _con dit ion s. _ Cancer _can _ be _ diff icul t_ to _ diag no se _and_ c an_ be _con sid er ed _ a_ " g reat _ im it at or " .
P e op le _m a y_ be co me _ an x ious_ or_ de pr es se d_ po st - diagnos is ._The_ ris k_ of_ su ic ide_ in_ peop le _ with _can c er_ is _ ap pr ox im ately_ do u bl e.

L oc al_ symp to m s
L oc al_ symp to m s_ may_ occur_ du e_ to _ the_ ma s s_of_ the_ tumor_ or_ its_ ul c er ation ._For_ exam pl e,_ ma s s_ effect s_ fr om _ lung _can c er _can _ bl oc k_ the_b ro n ch us _ result ing_ in _c oug h_ or_ p ne um on ia ;_ es op h ag e al _can c er _can _cause_ n ar ro wi ng _of_ the_ es op h ag us,_ ma kin g _ it _ diff icul t_ or_ pa in ful _ to _ s w al low ;_ and_ co lo rect al _can c er _m a y_ lead _ to _ n ar ro wi ng _or_ bl oc k ag es _ in_the_ bo we l ,_ affect ing_ bo we l _ h ab it s. _ M as se s_in_ bre as t s_or_ te st ic le s_ may_ pr od u c e_ ob se r v ab le _ lu mp s. _ U l c er ation _can _cause_ bl e ed ing_ that _can _ lead _ to _ symp to m s_ su ch _ as _c oug h ing_ up _ bl o od _ ( lung _can c er ),_ an em ia _or_ rect al_ bl e ed ing_ ( co lo n_ cancer ),_ bl o od _ in_the_ ur ine_ ( bl ad de r _can c er ),_ or_ ab no r ma l _ v ag inal_ bl e ed ing_ ( en do me tr ia l _ or _c er vi c al _can c er ) ._A l thoug h_ loc al iz ed _ pa in _m a y_ occur_ in_ advanc ed _can c er,_ the_ init ia l _ tumor_ is _ us u al ly _ pa in le s s. _ Some_ c anc ers_ c an _cause_ a_ bu il du p _of_ f lu id _ with in_the_ ch es t_ or_ ab do me n .

S ys te mic _ symp to m s
S ys te mic _ symp to m s_ may_ occur_ du e_ to _ the_ bo d y 's_ res po n se _ to _ the_c ancer ._Th is _m a y_ include _ f at ig u e,_ un in te n tion al_ we ight_ los s,_ or_ skin _ch ang es._ Some_ c anc ers_ c an _cause_ a_ system ic_ in f lam ma to r y_ stat e_ that _ lead s_ to _ ong o ing _m us c le _ los s_and_ we a k ne s s,_ known_ as _c ac he x ia .
Some_ cancer s,_ su ch _ as _ H od g kin 's_ diseas e,_ leuk em ia s,_ and_ li ve r _or_ k id ne y_ cancer s,_ c an _cause_ a_ pe r s is te n t_ fe ve r .
S ho r t ne s s_of_ bre at h ,_ c al le d_ d ys p ne a ,_ is _ a_ co m mo n_ symp to m _ of _can c er_ and_ its_ tr e at me n t ._Th e_c aus es _ of _can c er - rel at ed _ d ys p ne a_ c an_ include _ tum ors_ in_ or_ around_ the_ lung ,_ bl oc k ed _ a ir w a ys ,_ f lu id _ in_the_ lung s,_ p ne um on ia ,_ or_ tr e at me n t_ re ac tion s_ inclu di ng _ an_ al le r g ic_ res po n se ._T reat me n t_ for _ d ys p ne a_ in_ pa t i ent s_ with _ advanc ed _can c er _can _ include _ f ans ,_ bi le ve l _ ve n t il ation,_ ac up res su re / ref le x ol o g y_and_ mu l t ic om po ne n t_ no n ph ar ma co lo g ical _ in te r ve n tion s.
Some_ system ic_ symp to m s_ of _can c er_ are_ caus ed _ by_ ho r mo ne s_or_ ot he r _m ol e cul es _ pr od u c ed _ by_ the_ tumor ,_ known_ as _ pa ra ne op l as t ic_ syn dr om es._ C om mo n_ pa ra ne op l as t ic_ syn dr om es _ include _ hyper c al c em ia ,_wh ic h_ c an _cause_ al te red_ me n ta l _ stat e,_ co n st ip ation _and_ de h y dr ation,_ or_ hyp on at re m ia ,_wh ic h_ c an_ also_ caus e_ al te red_ me n ta l _ stat us,_ v om it ing,_ he ad ac he s,_ or_ se iz ur es.

Met as ta s is
Met as ta s is _ is _ the_s pr e ad _ of _can c er_ to _ ot he r _ loc ation s_in_ the_ bo d y. _ The_ dis pe r se d_ tum ors_ are_ c al le d_ me ta stat ic_ tumor s,_ wh ile_ the_ orig inal_ is _c al le d_ the_ primary_ tumor ._A l most_ all _can c ers_ c an _m et as ta s iz e. _ M os t_ c anc er_ de at h s_are_ du e_ to _can c er_ that _ h as _m et as ta s iz ed .
Met as ta s is _ is _com mo n_ in_the_ l ate_ stag es _ of _can c er_ and_ it _can _ occur_ vi a_ the_ bl o od _or_ the_ lymph atic_ system _or_ bo th ._The_ typ ical _ st ep s_ in _m et as ta s is _ ar e :

L oc al_ invas ion
In tr av as ation_ in to _ the_ bl o od _or_ lymph
C ir cul ation_ through_ the_ bo d y.
Ex tr av as ation_ in to _ the_ ne w_ tissu e
P ro life ra tion
A ng i ogenes is
Di ff er ent_ typ es _ of _can c ers_ te n d_ to _m et as ta s iz e_ to _ pa r t icul ar_ org an s. _ O ve ra l l ,_ the_ most _com mo n_ pl ac es _ for _m et as ta se s_ to _ occur_ are_ the_ lung s,_ li ve r ,_ bra in ,_and_ the_ bo ne s.
Wh ile_ som e_c anc ers_ c an_ be _c ur ed _ if_ de te ct ed _ ear ly ,_ me ta stat ic _can c er_ is _m ore_ diff icul t_ to _ tr e at_ and_ co n tr ol ._ N ev er th el ess ,_ som e_ rec ent_ tr e at me n t s_are_ de mo n st ra t ing_ en co ur aging_ result s.

C aus es
The_ maj or ity_ of _can c er s,_ som e_ 9 0 – 9 5 %_of _cas es,_ are_ du e_ to _ gen etic _m ut ations_ fr om _ en vi ro n me n ta l _and_ life st yl e_ fac to r s. _ The_ re ma in ing_ 5 – 10 %_ are_ du e_ to _ in he r it ed _ gen etic s. _ E n vi ro n me n ta l _ re fe r s_ to _ any_ caus e_ that _ is _ not_ in he r it ed ,_ su ch _ as _ life st yl e,_ e co no mic ,_and_ be hav i or al_ fac to r s_and_ not_ me re ly _ po l lut ion ._C om mo n_ en vi ro n me n ta l _ fac to r s_ that _con tr ibut e_ to _can c er_ de at h_ include _ tob ac co _ us e_ ( 2 5 – 3 0 % ),_ di et _and_ ob es ity_ ( 3 0 – 3 5 % ),_ infection s_( 1 5 – 20 % ),_ radiation_ ( bo th_ ionizing_ and_ no n - ion iz ing,_ up _ to _ 10 % ),_ l ac k_ of_ phys ical _ ac t iv it y, _and_ po l lut ion ._P sy ch ol o g ical _ st res s_ do es _ not_ appe ar_ to _ be _ a_ ris k_ fac to r _ for _ the_ on se t_ of _can c er,_ thoug h_ it _m a y_ wor se n_ out co me s_in_ those_ who_ al re ad y_ hav e_cancer .
E n vi ro n me n ta l _or_ life st yl e_ fac to r s_ that _caus ed _can c er_ to _ de ve lo p _ in_ an_ indi vidu al _can _ be _ id ent if i ed _ by_ an al y z ing _m ut ational_ sign at ur es _ fr om _ gen om ic_ sequenc ing_ of_ tumor_ DN A ._For_ exam pl e,_ th is _can _ re ve al_ if_ lung _can c er_ w as _caus ed _ by_ tob ac co _ smok e,_ if_ skin _can c er_ w as _caus ed _ by_ U V _ radi ation,_ or_ if_ se co n d ary_ c anc ers_ we re _caus ed _ by_ pr ev ious_ ch em ot he ra p y_ tr e at me n t .
C anc er_ is _ gener al ly _ not_ a_ transmis sib le _ diseas e. _ Ex c ep tion s_ include _ ra re _ transmis s ion s_ that _ occur_ with _ pr e gn anc i es _and_ oc c as ion al_ org an_ do no r s. _ H ow ever,_ transmis sib le _ infect ious_ diseas es _ su ch _ as _ he pa t it is _ B ,_ Ep st e in – B arr ,_ H P V _and_ A I D S _ infection s,_ c an _con tr ibut e_ to _ the_ de ve lo p me n t_ of _can c er .

Ch em ical s
Ex po su re _ to _ pa r t icul ar_ substanc es _ have_been_ li n k ed _ to _ spec ific _ typ es _ of _can c er ._These_ substanc es _ are_ c al le d_ c arcin ogen s.
T ob ac co _ smok e,_ for _ exam pl e,_ caus es _ 9 0 %_of _ lung _can c er ._T ob ac co _ us e_c an _caus e_c anc er_ throug ho ut _ the_ bo d y_ inclu di ng _ in_the_ mo ut h_ and_ thro at ,_ lar y n x ,_ es op h ag us,_ st om ach ,_ bl ad de r ,_ k id ne y, _c er vi x ,_ co lo n / rect um ,_ li ve r _and_ pa n cr e as ._T ob ac co _ smo ke_ co n ta in s_ over _ f if t y_ known_ c arcin ogen s,_ inclu di ng _ n it ro s am in es _and_ po ly c y c li c _ ar om atic_ h y dr oc ar bo n s.
T ob ac co _ is _ res po n sib le _ for _ about_ one_ in_ f ive_ c anc er_ de at h s_ world wi de _and_ about_ one_ in_ th ree_ in_the_ de ve lo pe d_ world .
L un g _can c er_ de at h_ ra te s_in_ the_ Un it ed _ St at es _ have_ m ir ro red_ smo kin g _ pa t te r n s,_ with _ in cr e as es _ in_ smo kin g _ fol lo we d_ by_ dr am atic_ in cr e as es _ in_ lung _can c er_ de at h_ ra te s_ and ,_ mo re _ rec ent ly ,_ de cr e as es _ in_ smo kin g _ ra te s_ s inc e_the_ 19 5 0 s_ fol lo we d_ by_ de cr e as es _ in_ lung _can c er_ de at h_ ra te s_ in _m en_ s inc e_ 19 9 0 .
A l co ho l _ in cr e as es _ the_ ris k_ of _can c er_ of_the_ bre as t_ ( in_ wom en ),_ thro at ,_ li ve r ,_ o es op h ag us,_ mo ut h ,_ lar y n x ,_and_ co lo n .
In _ W es te r n_ E ur op e,_ 10 %_of _can c ers_ in _m al es _and_ 3 %_of _can c ers_ in_ fe ma le s_are_ at tr ibut ed _ to _ al co ho l _ expo su re ,_ espec ia l ly _ li ve r _and_ di g es t ive_ tr ac t_ cancer s. _ C anc er_ fr om _ wor k - rel at ed _ substanc e_ expo su re s_ may_ caus e_ be tw e en_ 2 _and_ 20 %_of _cas es,_ caus ing_ at_ le as t_ 20 0 ,00 0_ de at h s. _ C anc ers_ su ch _ as _ lung _can c er_ and_ me s ot he li oma_ c an _com e_ fr om _ inh al ing_ tob ac co _ smo ke_ or_ as be st os _ f ib er s,_ or_ leuk em ia _ fr om _ expo su re _ to _ be n z en e.
Ex po su re _ to _ pe r f lu or o oc ta no ic_ ac id _ ( P F O A ),_ which_ is _ pr ed om in ant ly _ us ed _ in_the_ pr od u ct ion_ of_ T ef lo n ,_ is _ known_ to _cause_ tw o_ kin d s_ of _can c er .
Ch em ot he ra p y_ drug s_ su ch _ as _ pl at in um - b as ed _com po und s_are_ c arcin ogen s_ that _ in cr e as e_the_ ris k_ of_ se co n d ary_ cancer s.
A z at h i op r in e,_ an_ im mu no sup pr ess ive_ me di c ation,_ is _ a_ c arcin ogen _ that _can _cause_ primary_ tum ors_ to _ de ve lo p .

Di et _and_ ex er c is e
Di et ,_ phys ical _ in ac t iv it y, _and_ ob es ity_ are_ rel at ed _ to _ up _ to _ 3 0 – 3 5 %_of _can c er_ de at h s. _ In _ the_ Un it ed _ St at es,_ exc ess_ bo d y_ we ight_ is _ ass oc ia te d_ with _ the_ de ve lo p me n t_ of _m any_ typ es _ of _can c er_ and_ is _ a_ fac to r _ in_ 1 4 – 20 %_of _can c er_ de at h s. _ A_ U K _ stu d y_ inclu di ng _ d at a_ on_ over _ 5_ m il li on_ peop le _ sh ow ed _ h ig he r _ bo d y_ ma s s_ in de x _ to _ be _ rel at ed _ to _ at_ le as t_ 10 _ typ es _ of _can c er_ and_ res po n sib le _ for _ around_ 1 2 ,00 0_ c as es _ e ach_ year _ in_ that _c ountr y. _ P h ys ical _ in ac t iv ity_ is _ be li ev ed _ to _con tr ibut e_ to _can c er_ risk ,_ not_ on ly _ through_ its_ effect _ on_ bo d y_ we ight_ but_ also_ through_ ne g ativ e_ effect s_ on_the_ im mu ne _ system _and_ en do cr ine_ system ._M ore_ than_ h al f_ of_the_ effect _ fr om _ the_ di et _ is _ du e_ to _ over n ut r it ion_ ( e ating_ to o_ mu ch ),_ rather_ than_ fr om _ e ating_ to o_ fe w_ ve get ab le s_or_ ot he r _ health ful _ f o od s.
Some_ spec ific _ f o od s_are_ li n k ed _ to _ spec ific _can c er s. _ A_ high - s al t_ di et _ is _ li n k ed _ to _ g as tr ic _can c er ._A f l at ox in_ B 1 ,_ a_ fr e qu ent_ f o od _con ta m in ant ,_ caus es _ li ve r _can c er ._ B et el _ n ut _c he wi ng _can _cause_ or al _can c er ._ N ational_ differ enc es _ in_ di et ary_ pr ac t ic es _m a y_ pa r t ly _ ex pla in_ differ enc es _ in _can c er_ inc idenc e. _ F or_ exam pl e,_ g as tr ic _can c er_ is _m ore_ co m mo n_ in_ J ap an_ du e_ to _ its_ high - s al t_ di et _ wh ile_ co lo n_ c anc er_ is _m ore_ co m mo n_ in_the_ Un it ed _ St at es._ I m m ig ra n t_ c anc er_ pr of il es _m ir ro r _ those_ of_ their_ ne w_ co un tr y, _ of te n_ with in_ one_ gener ation .

In fect ion
W or l d wi de ,_ ap pr ox im ately_ 1 8 %_of _can c er_ de at h s_are_ rel at ed _ to _ infect ious_ diseas es._ Th is _ pr op or tion _ ra ng es _ fr om _ a_ high_ of_ 2 5 %_ in_ A fr ic a_ to _ le s s_ than_ 10 %_ in_the_ de ve lo pe d_ world ._ V ir us es _ are_ the_ us u al_ infect ious_ agent s_ that _caus e_c anc er_ but_ b ac te r ia _and_ pa ra sit es _m a y_ also_ pla y_ a_ ro le ._O n co vi r us es _ ( vi r us es _ that _can _cause_ hum an _can c er )_ include:

H um an_ pa p il lo ma vi r us _ ( c er vi c al _can c er ) ,
Ep st e in – B arr _ vi r us _ ( B -c ell_ lymp ho pr ol if er ativ e_ diseas e_and_ n as op har y ng e al _carcin oma ) ,
K ap os i 's_ s ar co ma _ he r pe s vi r us _ ( K ap os i 's_ s ar co ma _and_ primary_ ef f us ion_ lymp ho ma s ) ,
H ep at it is _ B _and_ he pa t it is _ C _ vi r us es _ ( he pa to c el lu lar _carcin oma )
H um an_ T -c ell_ leuk em ia _ vi r us - 1 _ ( T -c ell_ leuk em ia s ) .
M er k el _cell_ po ly om av ir us _ ( M er k el _cell _carcin oma )
B ac te r ia l _ infection _m a y_ also_ in cr e as e_the_ ris k_ of _can c er,_ as _ se en_ in

H el ic ob ac te r _ p yl or i -in duc ed _ g as tr ic _carcin oma .
C ol ib ac t in ,_ a_ gen ot ox in_ ass oc ia te d_ with _ E sc he r ic h ia _c ol i _ infect ion_ ( co lo rect al _can c er )
P ar as it ic_ infection s_ ass oc ia te d_ with _can c er_ include:

S ch is to som a_ h a em at ob i um _ ( s qu am ous_ c ell _carcin oma_ of_the_ bl ad de r )
The_ li ve r _ f lu k es,_ O p is th or ch is _ vi ve r r in i _and_ C lo no r ch is _ s in en s is _ ( ch ol ang i oc arcin oma ) .

Radi ation
Radiation_ expo su re _ su ch _ as _ ul tr av i ol et _ radi ation _and_ radi o ac t ive_ ma te r ia l _ is _ a_ ris k_ fac to r _ for _can c er ._M any_ no n - me l an oma_ skin _can c ers_ are_ du e_ to _ ul tr av i ol et _ radi ation,_ most ly _ fr om _ su n li g h t ._S ourc es _of_ ionizing_ radiation_ include _m ed ical _ im aging_ and_ ra do n_ g as .
I on izing_ radiation_ is _ not_ a_ pa r t icul ar ly _ st ro ng _m ut ag en ._ R es id ent ia l _ expo su re _ to _ ra do n_ g as ,_ for _ exam pl e,_ h as _ s imil ar _can c er_ risk s_ as _ pa s s ive_ smo kin g ._ Radiation_ is _ a_ mo re _ po te n t_ sourc e_ of _can c er_ wh en _com bi ne d_ with _ ot he r _can c er -c aus ing_ agent s,_ su ch _ as _ ra do n_ pl us _ tob ac co _ smok e. _ Radi ation _can _caus e_c anc er_ in _m os t_ pa r t s_of_ the_ bo d y, _ in_ all_ anim al s_and_ at_ any_ ag e. _ Ch il dr en_ are_ tw ic e_ as _ lik ely_ to _ de ve lo p _ radi ation -in duc ed _ leuk em ia _ as _ ad ult s ;_ radiation_ expo su re _ be for e_ bi r th_ h as _ te n_ tim es _ the_ effect .
M ed ical _ us e_of_ ionizing_ radiation_ is _ a_s ma l l _ but_ gro wi ng _ sourc e_of_ radi ation -in duc ed _can c er s. _ I on izing_ radi ation _m a y_ be _ us ed _ to _ tr e at_ ot he r _can c er s,_ but_ th is _m a y, _ in_ som e_c as es,_ in duc e_ a_ se co n d_ for m _ of _can c er ._I t_ is _ also_ us ed _ in_ som e_ kin d s_ of _m ed ical _ im ag ing .
P ro lo ng ed _ expo su re _ to _ ul tr av i ol et _ radiation_ fr om _ the_ su n_ c an_ lead _ to _m el an oma_ and_ ot he r _ skin _m al ign anc i es._ C le ar_ ev idenc e_ es ta bl is he s_ ul tr av i ol et _ radi ation,_ espec ia l ly _ the_ no n - ion iz ing _m ed i um _ w av e_ U V B ,_ as _ the_c aus e_ of _m os t_ no n - me l an oma_ skin _can c er s,_which_ are_ the_ most _com mo n_ for m s_ of _can c er_ in_the_ world .
N on - ionizing_ radi o_ fr e qu enc y_ radiation_ fr om _m ob ile_ ph on es,_ el e ct r ic_ po we r _ transmis s ion_ and_ ot he r _ s imil ar_ sourc es _ h as _ been_ de sc r ib ed _ as _ a_ po s sib le _carcin ogen _ by_ the_ W or ld_ H e al th_ O r g an iz ation 's_ In te r n ational_ A gen c y_ for _ R es ear ch _ on_ Cancer ._E vi de n c e,_ ho we ve r ,_ h as _ not_ sup po r te d_ a_ co n c er n ._Th is _ include s_ that _ studi es _ have_ not_ found_ a_ co n s is te n t_ li n k_ be tw e en _m ob ile_ ph one_ radi ation _and_ c anc er_ risk .

H er ed it y
The_ v as t_ maj or ity_ of _can c ers_ are_ no n - he re di ta r y_ ( s po radi c ) ._H er ed it ary_ c anc ers_ are_ prim ar ily_ caus ed _ by_ an_ in he r it ed _ gen etic _ defect ._ L ess_ than_ 0 . 3 %_of _ the_ po p ul ation_ are_ c arr i ers_ of_ a_ gen etic _m ut ation_ that _ h as _ a_ lar g e_ effect _ on _can c er_ ris k_ and_ these_ caus e_ le s s_ than_ 3 – 10 %_of _can c er ._S ome_ of_ these_ syn dr om es _ include :_ c erta in_ in he r it ed _m ut ation s_in_ the_ gen es _ B R C A 1 _and_ B R C A 2 _ with _ a_ mo re _ than_ 7 5 %_ ris k_ of_ bre as t_ c anc er_ and_ ov ar ia n_ c anc er,_ and_ he re di ta r y_ no n po ly po s is _c ol or e ct al _can c er_ ( H N P C C _or_ L y n ch _ syn dr om e ),_ which_ is _ pr es ent_ in_ about_ 3 %_of _ peop le _ with _c ol or e ct al _can c er,_ am ong_ ot he r s.
St at is t ical ly _ for _can c ers_ caus ing _m os t_ mo r ta li t y, _ the_ rel ativ e_ ris k_ of_ de ve lo p ing _c ol or e ct al _can c er_ when_ a_ fir st - de g ree_ rel ativ e_ ( pa re n t ,_ sib li ng _ or _chil d )_ h as _ been_ diag no se d_ with _ it _ is _ about_ 2 ._The_ co r res po n di ng _ rel ativ e_ ris k_ is _ 1. 5_ for _ lung _can c er,_ and_ 1. 9 _ for _ pr os ta te _can c er ._For_ bre as t_ c anc er,_ the_ rel ativ e_ ris k_ is _ 1. 8 _ with _ a_ fir st - de g ree_ rel ativ e_ hav ing_ de ve lo pe d_ it _ at_ 5 0_ year s_of_ age_ or_ ol de r ,_and_ 3 . 3 _ when_ the_ rel ativ e_ de ve lo pe d_ it _ when_ be ing_ y ou ng er_ than_ 5 0_ year s_of_ ag e.
T al le r _ peop le _ have_ an_ in cr e as ed _ ris k_ of _can c er_ becaus e_ they_ have_ mo re _cells_ than_ sh or te r _ peop le ._S inc e_ he ight_ is _ gen etic al ly _ de te r m in ed _ to _ a_ lar g e_ ex te n t ,_ ta l le r _ peop le _ have_ a_ he r it ab le _ in cr e as e_ in _can c er_ risk .

P h ys ical _ agent s
Some_ substanc es _caus e_c anc er_ prim ar ily_ through_ their_ phys ical ,_ rather_ th an _c he mic al ,_ effect s. _ A_ pr om in ent_ exam pl e_of_ th is _ is _ pr olon g ed _ expo su re _ to _ as be st os ,_ n at ur al ly _ occur r ing _m in er al_ f ib ers_ that _ are_ a_ maj or _cause_ of _m es ot he li oma_ ( c anc er_ of_the_ se ro us _m em bra ne )_ us u al ly _ the_ se ro us _m em bra ne _ sur ro un di ng _ the_ lung s. _ O ther_ substanc es _ in_ th is _c at e g or y, _ inclu di ng _ bo th_ n at ur al ly _ occur r ing_ and_ syn th etic _ as be st os - like_ f ib er s,_ su ch _ as _ w ol l as to n it e,_ at ta p ul g it e,_ g l ass_ w o ol _and_ ro c k_ w o ol ,_ are_ be li ev ed _ to _ have_ s imil ar_ effect s. _ N on - f ib ro us _ pa r t icul ate_ ma te r ia l s_ that _caus e_c anc er_ include _ po w de red_ me ta l li c _c ob al t_ and_ n ic k el _and_ cr ys ta l li ne _ s il ic a_ ( qu ar t z ,_ cr is tob al it e_and_ tr id y m it e ) ._ U su al ly ,_ phys ical _carcin ogen s_ mu st_ get _ in sid e_the_ bo d y_ ( su ch _ as _ through_ inh al ation )_ and_ requ ir e_ year s_of_ expo su re _ to _ pr od u c e_cancer .
P h ys ical _ tr a um a_ result ing_ in _can c er_ is _ rel ativ ely_ ra re ._C l a im s_ that _ bre a kin g _ bo ne s_ resul te d_ in_ bo ne _can c er,_ for _ exam pl e,_ have_ not_ been_ pr ov en ._S imil ar ly ,_ phys ical _ tr a um a_ is _ not_ acc ep te d_ as _ a_ caus e_ for _c er vi c al _can c er,_ bre as t_ c anc er_ or_ bra in _can c er ._O ne _ acc ep te d_ sourc e_ is _ fr e qu ent ,_ lo ng - te r m _ ap plic ation _of_ ho t_ ob j e ct s_ to _ the_ bo d y. _ I t_ is _ po s sib le _ that _ re pe at ed _ bu r n s_ on_the_ s ame_ pa r t_of_ the_ bo d y, _ su ch _ as _ those_ pr od u c ed _ by_ k ang er_ and_ k a ir o_ he at ers_ ( ch ar co al_ h and_ w ar me r s ),_ may_ pr od u c e_ skin _can c er,_ espec ia l ly _ if _carcin ogen ic _c he mic al s_are_ also_ pr es ent ._F requ ent_ co n su mp tion _of_ sc al di ng _ ho t_ te a_ may_ pr od u c e_ es op h ag e al _can c er ._ G en er al ly ,_ it _ is _ be li ev ed _ that _can c er_ aris es,_ or_ a_ pr e- ex is t ing _can c er_ is _ en co ur ag ed ,_ dur ing_the_ pr oc ess_ of_ heal ing,_ rather_ than_ di rect ly _ by_ the_ tr a um a ._H ow ever,_ re pe at ed _ in j ur i es _ to _ the_s ame_ tissu es _m ight_ pr om ot e_ exc ess ive_ c ell_ pr ol if er ation ,_wh ic h_ co ul d_ th en_ in cr e as e_the_ od d s_of_ a_ cancer ous_ mu ta tion .
Ch ro n ic_ in f lam ma tion _ h as _ been_ hyp ot he s iz ed _ to _ di rect ly _cause_ mu ta tion ._ In f lam ma tion _can _con tr ibut e_ to _ pr ol if er ation,_ sur vi v al ,_ ang i ogenes is _and_ m ig ra tion _ of _can c er _cells_ by_ in f lu enc ing_the_ tumor _m ic ro en vi ro n me n t ._O n co gen es _ bu il d_ up _ an_ in f lam ma to r y_ pr o - tum orig en ic _m ic ro en vi ro n me n t .

H or mo ne s
H or mo ne s_ also_ pla y_ a_ ro le _ in_the_ de ve lo p me n t_ of _can c er_ by_ pr om ot ing _cell_ pr ol if er ation ._ In su li n - like_ growth_ fac to r s_and_ their_ bi n di ng _ pr ot e in s_ pla y_ a_ k e y_ ro le _ in _can c er _cell_ pr ol if er ation,_ differ ent ia tion _and_ ap op to s is,_ su g g es t ing_ po s sib le _ inv ol ve me n t_ in _carcin ogenes is .
H or mo ne s_are_ im po r ta n t_ agent s_in_ se x - rel at ed _can c er s,_ su ch _ as _can c er_ of_the_ bre as t ,_ en do me tr i um ,_ pr os ta te ,_ ov ary_ and_ te st is _and_ also_ of_ th y ro id _can c er_ and_ bo ne _can c er ._For_ exam pl e,_ the_ d a ug h te r s_of_ wom en_ who_ have_ bre as t_ c anc er_ have_ sign ific ant ly _ h ig he r _ le ve l s_of_ es tr ogen _and_ pr o g es te ro ne _ than_ the_ d a ug h te r s_of_ wom en_ with out_ bre as t_ cancer ._These_ h ig he r _ ho r mo ne _ le ve l s_ may_ ex pla in_ their_ h ig he r _ ris k_ of_ bre as t_ c anc er,_ ev en_ in_the_ ab se n c e_of_ a_ bre as t -c anc er_ gen e. _ S imil ar ly ,_ me n_ of_ A fr ic an_ anc es tr y_ have_ sign ific ant ly _ h ig he r _ le ve l s_of_ te st os te ro ne _ th an _m en_ of_ E ur op e an_ anc es tr y_and_ have_ a_ co r res po n di ng ly _ h ig he r _ le ve l _of_ pr os ta te _can c er ._M en_ of_ A s ia n_ anc es tr y, _ with _ the_ lo we st_ le ve l s_of_ te st os te ro ne - ac t iv ating_ an dr os ta ne di ol _ g lu cur on id e,_ have_ the_ lo we st_ le ve l s_of_ pr os ta te _can c er .
O ther_ fac to r s_are_ re le v ant :_ ob ese_ peop le _ have_ h ig he r _ le ve l s_of_ som e_ ho r mo ne s_ ass oc ia te d_ with _can c er_ and_ a_ h ig he r _ ra te _of_ those_ cancer s. _ W om en_ who_ ta ke_ ho r mo ne _ re pl ac em ent_ therapy_ have_ a_ h ig he r _ ris k_ of_ de ve lo p ing _can c ers_ ass oc ia te d_ with _ those_ ho r mo ne s. _ O n_ the_ ot he r _ h and ,_ peop le _ who_ ex er c is e_ f ar _m ore_ than_ av er age_ have_ lo we r _ le ve l s_of_ these_ ho r mo ne s_and_ lo we r _ ris k_ of _can c er ._O st e os ar co ma _m a y_ be _ pr om ot ed _ by_ growth_ ho r mo ne s. _ Some_ tr e at me n t s_and_ pr ev ent ion_ ap pr o ac he s_ le ve ra g e_ th is _cause_ by_ ar t ific ia l ly _ reduc ing_ ho r mo ne _ le ve l s_and_ th us _ disc ou ra g ing_ ho r mo ne - se n sit ive_ cancer s.

A ut o im mu ne _ diseas es
Th ere_ is _ an_ ass oc ia tion _ be tw e en _c el ia c _ diseas e_and_ an_ in cr e as ed _ ris k_ of_ all _can c er s. _ P e op le _ with _ un tr e at ed _c el ia c _ disease_ have_ a_ h ig he r _ risk ,_but_ th is _ ris k_ de cr e as es _ with _ tim e_ af te r _ diagnos is _and_ str ic t_ tr e at me n t ._Th is _m a y_ be _ du e_ to _ the_ ad op tion _of_ a_ g lu te n - fr e e_ di et ,_wh ic h_ se em s_ to _ have_ a_ pr ot e ctive_ ro le _ again st_ the_ de ve lo p me n t_ of _m al ign anc y_ in_ peop le _ with _c el ia c _ diseas e. _ H ow ever,_ the_ de l a y_ in_ diagnos is _and_ init ia tion _of_ a_ g lu te n - fr e e_ di et _ se em s_ to _ in cr e as e_the_ ris k_ of _m al ign anc i es._ Ra te s_of_ g as tr o in te st in al _can c ers_ are_ in cr e as ed _ in_ peop le _ with _ C ro h n 's_ diseas e_and_ ul c er ativ e_ co li t is,_ du e_ to _ch ro n ic_ in f lam ma tion ._I m mu no mo du l at ors_ and_ bi ol o g ic_ agent s_ us ed _ to _ tr e at_ these_ diseas es _m a y_ pr om ot e_the_ de ve lo p me n t_of_ ex tr a -in te st in al _m al ign anc i es.

P at ho phys i ol o g y
G en etic s
C anc er_ is _ f und am en ta l ly _ a_ diseas e_of_ tissu e_ growth_ reg ul ation ._For_ a_ no r ma l _cell_ to _ trans for m _ in to _ a_ cancer _cell ,_ the_ gen es _ that _ reg ul ate_ c ell_ growth_ and_ differ ent ia tion _m us t_ be _ al te re d .
The_ affect ed _ gen es _ are_ di vi de d_ in to _ tw o_ b ro ad _c at e g or i es._ O n co gen es _ are_ gen es _ that _ pr om ot e_c ell_ growth_ and_ re pr od u ct ion ._T um or_ sup pr ess or_ gen es _ are_ gen es _ that _ inhibit _cell_ di vi s ion_ and_ sur vi v al ._M al ign ant_ trans for ma tion _can _ occur_ through_ the_ for ma tion _of_ no ve l _ on co gen es,_ the_ in ap pr op r ia te _ over - ex pr ess ion_ of_ no r ma l _ on co gen es,_ or_ by_ the_ un de r - ex pr ess ion_ or_ dis ab li ng _of_ tumor_ sup pr ess or_ gen es._ T yp ical ly ,_ ch ang es _ in _m ult ip le _ gen es _ are_ requ ir ed _ to _ trans for m _ a_ no r ma l _cell_ in to _ a_ cancer _cell .
G en etic _ch ang es _can _ occur_ at_ differ ent_ le ve l s_and_ by_ differ ent_ me ch an ism s. _ The_ g ain _or_ los s_of_ an_ ent ir e_ ch ro mo som e_c an_ occur_ through_ er ro r s_ in _m it os is ._M ore_ co m mo n_ are_ mu ta tion s,_which_ are_ ch ang es _ in_the_ n u c le ot ide_ sequenc e_of_ gen om ic_ DN A .
L ar g e- sc al e_ mu ta tion s_ inv ol ve _ the_ de le tion _or_ g ain _of_ a_ po r tion _of_ a_ ch ro mo som e. _ G en om ic_ am pl ific ation_ occur s_ when_ a_ c ell_ g ain s_ co p i es _ ( of te n_ 20 _ or _m or e )_ of_ a_s ma l l _ch ro mo som al_ loc us,_ us u al ly _con ta in ing_ one_ or _m ore_ on co gen es _and_ ad j ac ent_ gen etic _m at er ia l ._T ra n s loc ation_ occur s_ when_ tw o_ se pa ra te _ch ro mo som al_ reg ion s_ be co me _ ab no r ma l ly _ f us ed ,_ of te n_ at_ a_ ch ar ac te ris t ic_ loc ation ._A_ we l l - known_ exam pl e_of_ th is _ is _ the_ P h il ad el ph ia _ch ro mo som e,_ or_ trans loc ation_ of _ch ro mo som es _ 9 _and_ 2 2 ,_wh ic h_ occur s_ in _ch ro n ic _m y el ogen ous_ leuk em ia _and_ result s_in_ pr od u ct ion_ of_the_ B C R - abl _ f us ion_ pr ot e in ,_ an_ on co gen ic_ t y ro s ine_ kin as e.
S ma l l - sc al e_ mu ta tion s_ include _ po in t_ mu ta tion s,_ de le tion s,_ and_ in se r tion s,_which_ may_ occur_ in_the_ pr om ot er_ reg ion_ of_ a_ gen e_and_ affect _ its_ ex pr ess ion ,_ or _m a y_ occur_ in_the_ gen e 's_ co di ng _ sequenc e_and_ al te r _ the_ f un ct ion_ or_ st abil ity_ of_ its_ pr ot e in_ pr od u ct ._ Di s r up tion _of_ a_s ing le _ gen e_ may_ also_ resul t_ fr om _ in te g ra tion _of_ gen om ic _m at er ia l _ fr om _ a_ DNA_ vi r us _or_ re tr ov ir us,_ lead ing_ to _ the_ ex pr ess ion_ of_ vi ra l _ on co gen es _ in_the_ affect ed _cell _and_ its_ de sc end ant s.
R ep li c ation _of_ the_ d at a_ co n ta in ed _ with in_the_ DNA_ of_ li vi ng _cells_ wi l l _ pr ob abil is t ical ly _ resul t_ in_ som e_ er ro r s_( mu ta tion s ) ._C om pl ex _ er ro r _c or rect ion_ and_ pr ev ent ion_ are_ bu il t_ in to _ the_ pr oc ess_ and_ s af e g u ar d_ the_c ell_ again st _can c er ._I f_ a_s ign ific ant_ er ro r _ occur s,_ the_ damag ed _cell _can _ se l f - de str u ct _ through_ pr o g ra m me d_ c ell_ de at h ,_ te r me d_ ap op to s is ._I f_ the_ er ro r _con tr ol _ pr oc es se s_ f a il ,_ th en_ the_ mu ta tion s_ wi l l _ sur vi ve _and_ be _ pa s se d_ al ong_ to _ d a ug h te r _cell s.
Some_ en vi ro n me n t s_ ma ke_ er ro r s_ mo re _ lik ely_ to _ aris e_and_ pr op ag at e. _ S u ch _ en vi ro n me n t s_c an_ include _ the_ pr es enc e_of_ dis r up t ive_ substanc es _c al le d_ c arcin ogen s,_ re pe at ed _ phys ical _ in j ur y, _ he at ,_ ion is ing_ radi ation,_ or_ hyp ox ia .
The_ er ro r s_ that _caus e_c anc er_ are_ se l f - am pl if y ing_ and_ co mp oun di ng ,_ for _ exam pl e :

A_ mu ta tion _ in_the_ er ro r -c or rect ing _m ach in er y_of_ a_ c ell _m ight_ caus e_ that _cell _and_ its_ ch il dr en_ to _ acc um ul ate_ er ro r s_ mo re _ ra p id ly .
A_ f ur ther _m ut ation_ in_ an_ on co gen e_ m ight_ caus e_the_ c ell_ to _ re pr od u c e_ mo re _ ra p id ly _and_ mo re _ fr e qu ent ly _ than_ its_ no r ma l _c oun te r pa r t s.
A_ f ur ther _m ut ation _m a y_ caus e_the_ los s_of_ a_ tumor_ sup pr ess or_ gen e,_ dis r up t ing_the_ ap op to s is _ sign al ing_ pa th w a y_and_ im mo r ta li z ing_ the_c ell .
A_ f ur ther _m ut ation_ in_the_ sign al ing _m ach in er y_of_ the_c ell _m ight_ se n d_ er ro r -c aus ing_ sign al s_ to _ ne ar by_ c ell s.
The_ trans for ma tion _of_ a_ no r ma l _cell_ in to _can c er_ is _ a kin _ to _ a_ ch ain _ re ac tion _caus ed _ by_ init ia l _ er ro r s,_which_ co mp ound_ in to _m ore_ se ve re _ er ro r s,_ e ach_ pr o g ress iv ely_ al lo wi ng _ the_c ell_ to _ es c ap e_ mo re _con tr ol s_ that _ li m it _ no r ma l _ tissu e_ grow th ._Th is _ re be l li on - like_ sc en ari o_ is _ an_ un de s ir ab le _ sur vi v al_ of_the_ f it te st ,_wh ere_ the_ dr iv ing_ for c es _of_ ev ol ut ion_ wor k_ again st_ the_ bo d y 's_ de s ig n_ and_ en for c em ent_ of_ or de r ._O n c e_c anc er_ h as _ be g un _ to _ de ve lo p ,_ th is _ ong o ing_ pr oc ess ,_ te r me d_ c lo n al_ ev ol ut ion ,_ dr iv es _ pr o g ress ion_ to w ar d s_ mo re _ invas ive_ stag es._ C lo n al_ ev ol ut ion_ lead s_ to _ in tr a - tum our _ he te ro gen e ity_ ( cancer _cells_ with _ he te ro gen e ous_ mu ta tion s )_ that _com plic at es _ de sign ing_ effect ive_ tr e at me n t_ st ra te g i es _and_ requ ir es _ an_ ev ol ut ion ary_ ap pr o ach_ to _ de sign ing_ tr e at me n t .
Ch ar ac te ris t ic_ abil it i es _ de ve lo pe d_ by_ c anc ers_ are_ di vi de d_ in to _c at e g or i es,_ spec ific al ly _ ev as ion_ of_ ap op to s is,_ se l f - suff ici enc y_ in_ growth_ sign als ,_ in se n sit iv ity_ to _ ant i - growth_ sign als ,_ su st ain ed _ ang i ogenes is,_ li m it le s s_ re plic ativ e_ po te n t ia l ,_ me ta st as is,_ re pr o g ra m m ing_ of_ energy_ me ta bo li s m _and_ ev as ion_ of_ im mu ne _ de str u ct ion .

Ep igen etic s
The_ c l ass ical _ vie w_ of _can c er_ is _ a_ se t_of_ diseas es _ dr iv en_ by_ pr o g ress ive_ gen etic _ ab no r ma li t i es _ that _ include _m ut ation s_in_ tumor - sup pr ess or_ gen es _and_ on co gen es,_ and_ in _ch ro mo som al_ ab no r ma li t i es._ A_ ro le _ for _ ep igen etic _ al te ra tion s_ w as _ id ent if i ed _ in_the_ ear ly _ 2 1 st _c ent ur y.
Ep igen etic _ al te ra tion s_are_ f un ct ion al ly _ re le v ant_ mo di f ic ations_ to _ the_ gen ome_ that _ do _ not_ ch ang e_the_ n u c le ot ide_ sequenc e. _ Ex am pl es _of_ su ch _m od ific ation s_are_ ch ang es _ in_ DNA_ meth yl ation_ ( hyper meth yl ation _and_ hyp om et h yl ation ),_ h is to ne _m od ific ation _and_ ch ang es _ in _ch ro mo som al_ ar ch it e ct ure_ ( caus ed _ by_ in ap pr op r ia te _ ex pr ess ion_ of_ pr ot e in s_ su ch _ as _ H M G A 2 _or_ H M G A 1 ) ._E ach_ of_ these_ al te ra tion s_ reg ul at es _ gen e_ ex pr ess ion_ with out_ al te r ing_the_ un de r ly ing_ DNA_ sequenc e. _ Th ese_ ch ang es _m a y_ re ma in_ through_ c ell_ di vi s ion s,_ en du re _ for _m ult ip le _ gener ation s,_ and_c an_ be _con sid er ed _ as _ e qu iv al ent_ to _m ut ation s.
Ep igen etic _ al te ra tion s_ occur_ fr e qu ent ly _ in _can c er s. _ A s_ an_ exam pl e,_ one_ stu d y_ li st ed _ pr ot e in _c od ing_ gen es _ that _ we re _ fr e qu ent ly _ al te red_ in_ the ir _m et h yl ation_ in_ ass oc ia tion _ with _c olon _can c er ._These_ include d_ 1 4 7 _ hyper meth yl at ed _and_ 2 7 _ hyp om et h yl at ed _ gen es._ O f_ the_ hyper meth yl at ed _ gen es,_ 10 _ we re _ hyper meth yl at ed _ in_ 10 0 %_of _c olon _can c ers_ and_ ma n y_ ot he r s_ we re _ hyper meth yl at ed _ in _m ore_ than_ 5 0 %_of _c olon _can c er s.
Wh ile_ ep igen etic _ al te ra tion s_are_ found_ in _can c er s,_ the_ ep igen etic _ al te ra tion s_in_ DNA_repair_ gen es,_ caus ing_ reduc ed _ ex pr ess ion_ of_ DNA_repair_ pr ot e in s,_ may_ be _of_ pa r t icul ar_ im po r ta n c e. _ S u ch _ al te ra tion s_ may_ occur_ ear ly _ in_the_ pr o g ress ion_ to _can c er_ and_ are_ a_ po s sib le _caus e_of_the_ gen etic _ in st abil ity_ ch ar ac te ris t ic_ of _can c er s.
R ed u c ed _ ex pr ess ion_ of_ DNA_repair_ gen es _ dis r up t s_ DNA_ repa ir ._Th is _ is _ sh ow n_ in_the_ f ig ure_ at_ the_ 4 th_ le ve l _ fr om _ the_ to p ._ ( In _ the_ f ig ur e,_ red_ wor di ng _ indi c at es _ the_c en tr al_ ro le _of_ DNA_ dam age_ and_ defect s_in_ DNA_repair_ in_the_ pr o g ress ion_ to _can c er . )_ Wh en_ DNA_repair_ is _ def ici ent_ DNA_ dam age_ re ma in s_ in _cells_ at_ a_ h ig he r _ than_ us u al_ le ve l _ ( 5 th_ le ve l )_ and_c aus es _ in cr e as ed _ fr e qu enc i es _ of _m ut ation_ and / or_ ep im ut ation_ ( 6 th_ le ve l ) ._M ut ation_ ra te s_ in cr e as e_ sub st ant ia l ly _ in _cells_ defect ive_ in_ DNA_ mis ma t ch _ repair_ or_ in_ ho mo lo g ous_ re co m bi n ational_ repair_ ( H R R ) ._ Ch ro mo som al_ re ar ra ng em ent s_and_ ane up lo id y_ also_ in cr e as e_ in_ H R R _ defect ive_ c ell s.
H ig he r _ le ve l s_of_ DNA_ dam age_ caus e_ in cr e as ed _m ut ation_ ( r ight_ sid e_of_ f ig ur e )_ and_ in cr e as ed _ ep im ut ation ._ D ur ing_ repair_ of_ DNA_ do u bl e_ st ra n d_ bre a k s,_ or_ repair_ of_ ot he r _ DNA_ damag e,_ in co mp le te ly _c le ar ed _ repair_ sit es _can _cause_ ep igen etic _ gen e_ s il enc ing .
D ef ici ent_ ex pr ess ion_ of_ DNA_repair_ pr ot e in s_ du e_ to _ an_ in he r it ed _m ut ation _can _ in cr e as e_c anc er_ risk s. _ In di vidu al s_ with _ an_ in he r it ed _ im pa ir me n t_ in_ any_ of_ 3 4 _ DNA_repair_ gen es _ ( se e_ ar t ic le _ DNA_ repa ir - def ici enc y_ dis or de r )_ have_ in cr e as ed _can c er_ risk ,_ with _ som e_ defect s_ en sur ing_ a_ 10 0 %_ life tim e_ ch anc e_ of _can c er_ ( e. g ._ p 5 3 _m ut ation s ) ._ G er m li ne _ DNA_ repa ir _m ut ation s_are_ no te d_ on_the_ f ig ur e 's_ le f t_ sid e. _ H ow ever,_ su ch _ ger m li ne _m ut ation s_( which_ caus e_ high ly _ pe ne tr ant_ c anc er_ syn dr om es )_ are_ the_c aus e_of_ on ly _ about_ 1 _ pe r c ent_ of _can c er s.
In _ s po radi c _can c er s,_ def ici enc i es _ in_ DNA_repair_ are_ oc c as ion al ly _caus ed _ by_ a_ mu ta tion _ in_ a_ DNA_repair_ gen e_ but_ are_ mu ch _m ore_ fr e qu ent ly _caus ed _ by_ ep igen etic _ al te ra tion s_ that _ reduc e_ or_ s il enc e_ ex pr ess ion_ of_ DNA_repair_ gen es._ Th is _ is _ indi c at ed _ in_the_ f ig ure_ at_ the_ 3 r d_ le ve l ._M any_ studi es _of_ he av y_ me ta l -in duc ed _carcin ogenes is _ sh ow _ that _ su ch _ he av y_ me ta l s_c aus e_ a_ re duct ion_ in_ ex pr ess ion_ of_ DNA_repair_ en z y me s,_ som e_ through_ ep igen etic _m e ch an ism s. _ DNA_repair_ inhibit ion_ is _ pr op os ed _ to _ be _ a_ pr ed om in ant_ me ch an ism _ in_ he av y_ me ta l -in duc ed _carcin ogen ic it y. _ In _ ad dit ion ,_ fr e qu ent_ ep igen etic _ al te ra tion s_of_ the_ DNA_ sequenc es _c od e_ for _ s ma l l _ R N A s_c al le d_ mic ro R N A s_( or _m i R N A s ) ._ m i R N A s_ do _ not_ co de _ for _ pr ot e in s,_ but_ c an_ " ta r get "_ pr ot e in -c od ing_ gen es _and_ reduc e_ their_ ex pr ess ion .
C anc ers_ us u al ly _ aris e_ fr om _ an_ as se m bl age_ of _m ut ation s_and_ ep im ut ations_ that _con fe r _ a_ se le ctive_ adv an ta g e_ lead ing_ to _c lo n al_ ex pa n s ion_ ( se e_ F i el d_ defect s_in_ pr o g ress ion_ to _can c er ) ._M ut ation s,_ ho we ve r ,_ may_ not_ be _ as _ fr e qu ent_ in _can c ers_ as _ ep igen etic _ al te ra tion s. _ A n_ av er age_ c anc er_ of_the_ bre as t_ or _c olon _can _ have_ about_ 6 0_ to _ 7 0_ pr ot e in - al te r ing _m ut ation s,_ of_ which_ about_ th ree_ or_ f our _m a y_ be _ " dr iv er "_ mu ta tion s_and_ the_ re ma in ing_ on es _m a y_ be _ " pa s se ng er "_ mu ta tion s.

Met as ta s is
Met as ta s is _ is _ the_s pr e ad _ of _can c er_ to _ ot he r _ loc ation s_in_ the_ bo d y. _ The_ dis pe r se d_ tum ors_ are_ c al le d_ me ta stat ic_ tumor s,_ wh ile_ the_ orig inal_ is _c al le d_ the_ primary_ tumor ._A l most_ all _can c ers_ c an _m et as ta s iz e. _ M os t_ c anc er_ de at h s_are_ du e_ to _can c er_ that _ h as _m et as ta s iz ed .
Met as ta s is _ is _com mo n_ in_the_ l ate_ stag es _ of _can c er_ and_ it _can _ occur_ vi a_ the_ bl o od _or_ the_ lymph atic_ system _or_ bo th ._The_ typ ical _ st ep s_ in _m et as ta s is _ are_ loc al_ invas ion ,_ in tr av as ation_ in to _ the_ bl o od _or_ lymph ,_ c ir cul ation_ through_ the_ bo d y, _ ex tr av as ation_ in to _ the_ ne w_ tissu e,_ pr ol if er ation _and_ ang i ogenes is ._ Di ff er ent_ typ es _ of _can c ers_ te n d_ to _m et as ta s iz e_ to _ pa r t icul ar_ org ans ,_but_ over all_ the_ most _com mo n_ pl ac es _ for _m et as ta se s_ to _ occur_ are_ the_ lung s,_ li ve r ,_ bra in_ and_ the_ bo ne s.

Met ab ol ism
N or ma l _cells_ typ ical ly _ gener ate_ about_ 3 0 %_of _ energy_ fr om _ g ly co ly s is,_ wh ere as _m os t_ c anc ers_ re ly _ on_ g ly co ly s is _ for _ energy_ pr od u ct ion_ ( W ar bu r g _ effect ) ._ B ut _ a_ m in or ity_ of _can c er_ typ es _ re ly _ on_ ox id ativ e_ ph os ph or yl ation_ as _ the_ primary_ energy_ sourc e,_ inclu di ng _ lymp ho ma ,_ leuk em ia ,_and_ en do me tr ia l _can c er ._E ve n_ in_ these_ c as es,_ ho we ve r ,_ the_ us e_of_ g ly co ly s is _ as _ an_ energy_ sourc e_ ra re ly _ exc e ed s_ 6 0 % ._A_ fe w_ c anc ers_ us e_ g lu ta m ine_ as _ the_ maj or_ energy_ sourc e,_ pa r t ly _ becaus e_ it _ pr ov id es _ n it ro gen _ requ ir ed _ for _ n u c le ot ide_ ( DN A ,_ R N A )_ syn th es is ._C anc er_ stem _cells_ of te n_ us e_ ox id ativ e_ ph os ph or yl ation _or_ g lu ta m ine_ as _ a_ primary_ energy_ sourc e.

Di ag nos is
M os t_ c anc ers_ are_ init ia l ly _ re co gn iz ed _ e it he r _ becaus e_of_the_ appe ar anc e_of_ sign s_or_ symp to m s_or_ through_ screen ing ._ N e it he r _of_ these_ lead s_ to _ a_ def init ive_ diagnos is,_ which_ requ ir es _ the_ exam in ation _of_ a_ tissu e_ s am pl e_ by_ a_ pa th ol o g is t ._P e op le _ with _ su s pe ct ed _can c er_ are_ in ve st ig at ed _ with _m ed ical _ te st s. _ Th ese_ co m mo n ly _ include _ bl o od _ te st s,_ X - ra ys ,_ ( co n tr as t )_ C T _ sc an s_and_ en do sc op y.
The_ tissu e_ diagnos is _ fr om _ the_ bi op sy _ indi c at es _ the_ typ e_ of _cell_ that _ is _ pr ol if er at ing,_ its_ h is to lo g ical _ g ra de ,_ gen etic _ ab no r ma li t i es _and_ ot he r _ fe at ur es._ T o get he r ,_ th is _ in for ma tion _ is _ us ef ul _ to _ ev al u ate_ the_ pr o gn os is _and_ to _c ho ose_ the_ be st_ tr e at me n t .
C y to gen etic s_and_ im mu no h is to ch em is tr y_ are_ ot he r _ typ es _of_ tissu e_ te st s. _ Th ese_ te st s_ pr ov ide_ in for ma tion _ about_ mo le cul ar _ch ang es _ ( su ch _ as _m ut ation s,_ f us ion_ gen es _and_ n um er ical _ch ro mo som e_ ch ang es )_ and_ may_ th us _ also_ indi c ate_ the_ pr o gn os is _and_ be st_ tr e at me n t .
C anc er_ diagnos is _can _cause_ p sy ch ol o g ical _ di st res s_and_ p sy ch os oc ia l _ in te r ve n tion s,_ su ch _ as _ ta l kin g _ therap y, _m a y_ he l p _ peop le _ with _ th is ._S ome_ peop le _c ho ose_ to _ disc lo se _ the_ diagnos is _ wi de ly ;_ ot he r s_ pr ef er_ to _ k e ep _ the_ in for ma tion _ pr iv at e,_ espec ia l ly _ sh or t ly _ af te r _ the_ diagnos is,_ or_ to _ disc lo se _ it _ on ly _ pa r t ia l ly _or_ to _ se le ct ed _ peop le .

C l ass ific ation
C anc ers_ are_ c l ass if i ed _ by_ the_ typ e_ of _cell_ that _ the_ tumor _cells_ rese m bl e_and_ is _ ther ef ore_ pr es um ed _ to _ be _ the_ orig in_ of_the_ tumor ._These_ typ es _ include:

C arcin oma :_ C anc ers_ de r iv ed _ fr om _ ep it he li al _cell s. _ Th is _ gro up _ include s_ ma n y_of_ the_ most _com mo n_ c anc ers_ and_ include _ ne ar ly _ all_ those_ in_the_ bre as t ,_ pr os ta te ,_ lung ,_ pa n cr e as _and_ co lo n ._M os t_of_ these_ are_ of_the_ ad en oc arcin oma_ typ e,_ which_ me an s_ that _ the_c anc er_ h as _ g l and - like_ differ ent ia tion .
S ar co ma :_ C anc ers_ aris ing_ fr om _con ne ctive_ tissu e_ ( i . e. _ bo ne ,_ c ar t il ag e,_ f at ,_ ne r ve ),_ e ach_ of_ which_ de ve lo p s_ fr om _cells_ orig in ating_ in _m es en ch y ma l _cells_ out sid e_the_ bo ne _m ar ro w .
L y mp ho ma _and_ leuk em ia :_ Th ese_ tw o_ c l as se s_ aris e_ fr om _ he ma to po i etic _ ( bl o od - for m ing )_ c ell s_ that _ le av e_the_ ma r ro w_ and_ te n d_ to _m at ure_ in_the_ lymp h_ no de s_and_ bl o od ,_ res pe ct iv el y.
G er m _cell_ tumor :_ C anc ers_ de r iv ed _ fr om _ pl ur ip ot ent_ c ell s,_ most_ of te n_ pr es ent ing_ in_the_ te st ic le _or_ the_ ov ary_ ( se m in oma_ and_ d ys ger m in oma,_ res pe ct iv el y ) .
B l as to ma :_ C anc ers_ de r iv ed _ fr om _ im ma t ure_ " pr e cur s or "_ c ell s_or_ em b r y on ic_ tissu e.
C anc ers_ are_ us u al ly _ n am ed _ us ing_ -c arcin oma,_ - s ar co ma _or_ - bl as to ma _ as _ a_ suff ix ,_ with _ the_ L at in_ or_ G re e k_ wor d_ for _ the_ org an_ or_ tissu e_of_ orig in_ as _ the_ ro ot ._For_ exam pl e,_ c anc ers_ of_the_ li ve r _ pa re n ch y ma _ aris ing_ fr om _m al ign ant_ ep it he li al _cells_ is _c al le d_ he pa to c arcin oma ,_wh ile_ a_ ma li gn anc y_ aris ing_ fr om _ prim it ive_ li ve r _ pr e cur s or _cells_ is _c al le d_ a_ he pa to bl as to ma _and_ a_ c anc er_ aris ing_ fr om _ f at _cells_ is _c al le d_ a_ li po s ar co ma ._For_ som e_ co m mo n_ cancer s,_ the_ E ng li sh _ org an_ n ame_ is _ us ed ._For_ exam pl e,_ the_ most _com mo n_ typ e_of_ bre as t_ c anc er_ is _c al le d_ duct al _carcin oma_ of_the_ bre as t ._H ere ,_ the_ ad j e ctive_ duct al_ re fe r s_ to _ the_ appe ar anc e_ of _can c er_ un de r _ the_ mic ro sc op e,_ which_ su g g es t s_ that _ it _ h as _ orig in at ed _ in_the_ m il k_ duct s.
B en ig n_ tum ors_ ( which_ are_ not_ cancer s )_ are_ n am ed _ us ing_ - oma_ as _ a_ suff ix _ with _ the_ org an_ n ame_ as _ the_ ro ot ._For_ exam pl e,_ a_ be n ig n_ tumor_ of_ smo ot h_ mu sc le _cells_ is _c al le d_ a_ le i om y oma_ ( the_ co m mo n_ n ame_ of_ th is _ fr e qu ent ly _ occur r ing_ be n ig n_ tumor_ in_the_ ut er us _ is _ f ib ro id ) ._C on f us ing ly ,_ som e_ typ es _ of _can c er_ us e_the_ - no ma _ suff ix ,_ exam pl es _ inclu di ng _m el an oma_ and_ se m in oma .
Some_ typ es _ of _can c er_ are_ n am ed _ for _ the_s iz e_and_ sh ap e_of_ the_c ell s_ un de r _ a_ mic ro sc op e,_ su ch _ as _ g ia n t_ c ell _carcin oma,_ s p ind le _cell _carcin oma_ and_ s ma l l -c ell _carcin oma .

P re ve n tion
C anc er_ pr ev ent ion_ is _ def in ed _ as _ ac t ive_ me as ur es _ to _ de cr e as e_c anc er_ risk ._The_ v as t_ maj or ity_ of _can c er _cas es _ are_ du e_ to _ en vi ro n me n ta l _ ris k_ fac to r s. _ M any_ of_ these_ en vi ro n me n ta l _ fac to r s_are_ co n tr ol l ab le _ life st yl e_ ch o ic es._ Th us,_ c anc er_ is _ gener al ly _ pr ev en ta bl e. _ B et we en_ 7 0 %_ and_ 9 0 %_of _com mo n_ c anc ers_ are_ du e_ to _ en vi ro n me n ta l _ fac to r s_and_ ther ef ore_ po te n t ia l ly _ pr ev en ta bl e.
G reat er_ than_ 3 0 %_of _can c er_ de at h s_ co ul d_ be _ pr ev en te d_ by_ av o id ing_ ris k_ fac to r s_ inclu di ng :_ tob ac co ,_ exc ess_ we ight / ob es it y, _ po or_ di et ,_ phys ical _ in ac t iv it y, _ al co ho l ,_ se x u al ly _ trans m it te d_ infection s_and_ a ir_ po l lut ion ._F ur ther ,_ po ve r t y_ co ul d_ be _con sid er ed _ as _ an_ indi rect _ ris k_ fac to r _ in_ hum an _can c er s. _ N ot _ all_ en vi ro n me n ta l _caus es _ are_ co n tr ol l ab le ,_ su ch _ as _ n at ur al ly _ occur r ing_ b ac k gro un d_ radi ation _and_ c anc ers_ caus ed _ through_ he re di ta r y_ gen etic _ dis or de r s_and_ th us _ are_ not_ pr ev en ta bl e_ vi a_ pe r s on al_ be hav i or .
In _ 20 19 ,_ ~ 4 4 %_of _ all _can c er_ de at h s_ – _or_ ~ 4 . 5_ M _ de at h s_or_ ~ 10 5_ m il li on_ lo st_ dis abil it y - ad j us te d_ life _ year s_ – _ we re _ du e_ to _ known_ c le ar ly _ pr ev en ta bl e_ ris k_ fac to r s,_ le d_ by_ smo kin g ,_ al co ho l _ us e_and_ high_ B M I ,_ ac co r di ng _ to _ a_ G B D _ system atic_ an al ys is .

Di et ar y
Wh ile_ ma n y_ di et ary_ re co m me n d ations_ have_been_ pr op os ed _ to _ reduc e_c anc er_ risk s,_ the_ ev idenc e_ to _ sup po r t_ th em _ is _ not_ def init iv e. _ The_ primary_ di et ary_ fac to r s_ that _ in cr e as e_ ris k_ are_ ob es ity_ and_ al co ho l _con su mp tion ._ Di et s_ lo w_ in_ fr u its_ and_ ve get ab le s_and_ high_ in_ red_ me at_ have_been_ im plic at ed _ but_ re vie w s_and_ me ta - an al ys es _ do _ not_ co me _ to _ a_ co n s is te n t_ co n c lu s ion ._A_ 201 4 _m et a - an al ys is _ found_ no _ rel ation sh ip _ be tw e en_ fr u its_ and_ ve get ab le s_and_ cancer ._C of fe e_ is _ ass oc ia te d_ with _ a_ reduc ed _ ris k_ of_ li ve r _can c er ._ St u di es _ have_ li n k ed _ exc ess ive_ co n su mp tion _of_ red_ or_ pr oc es se d_ me at_ to _ an_ in cr e as ed _ ris k_ of_ bre as t_ c anc er,_ co lo n_ c anc er_ and_ pa n cr e at ic _can c er,_ a_ ph en om en on_ that _c ould_ be _ du e_ to _ the_ pr es enc e_ of _carcin ogen s_ in _m e at s_ co o k ed _ at_ high_ te mp er at ur es._ In _ 201 5_ the_ I A R C _ re po r te d_ that _ e ating_ pr oc es se d_ me at_ ( e. g . ,_ b ac on ,_ h am ,_ ho t_ do g s,_ s aus ag es )_ and ,_ to _ a_ le s se r _ de g re e,_ red_ me at_ w as _ li n k ed _ to _ som e_cancer s.
Di et ary_ re co m me n d ations_ for _can c er_ pr ev ent ion_ typ ical ly _ include _ an_ em ph as is _ on_ ve get ab le s,_ fr u it ,_wh ol e_ g ra in s_and_ f is h_ and_ an_ av o id anc e_of_ pr oc es se d_ and_ red_ me at_ ( be ef ,_ po r k ,_ lam b ),_ anim al_ f at s,_ p ic k le d_ f o od s_and_ ref in ed _c ar bo h y dr at es.

M ed ic ation
M ed ic ation s_c an_ be _ us ed _ to _ pr ev ent_ c anc er_ in_ a_ fe w_ c ir c um stanc es._ In _ the_ gener al_ po p ul ation,_ N S A I D s_ reduc e_the_ ris k_ of _c ol or e ct al _can c er ;_ ho we ve r ,_ du e_ to _c ar di ov as cul ar_ and_ g as tr o in te st inal_ sid e_ effect s,_ they_ caus e_ over all_ har m _ when_ us ed _ for _ pr ev ent ion ._A s p ir in_ h as _ been_ found_ to _ reduc e_the_ ris k_ of_ de at h_ fr om _can c er_ by_ about_ 7 % ._C O X - 2 _ inhibit ors_ may_ de cr e as e_the_ ra te _of_ po ly p _ for ma tion _ in_ peop le _ with _ f am il ia l _ ad en om at ous_ po ly po s is ;_ ho we ve r ,_ it _ is _ ass oc ia te d_ with _ the_s ame_ ad ve r se _ effect s_ as _ N S A I D s. _ D a ily_ us e_of_ ta mo x if en_ or_ ra lo x if en e_ reduc e_the_ ris k_ of_ bre as t_ c anc er_ in_ high - ris k_ wom en ._The_ be ne f it _ ve r su s_ har m _ for _ 5 - al ph a - re duct as e_ inhibit or_ su ch _ as _ f in as te r ide_ is _ not_ c le ar .
V it am in_ sup pl em en ta tion _ do es _ not_ appe ar_ to _ be _ effect ive_ at_ pr ev ent ing _can c er ._ Wh ile_ lo w_ bl o od _ le ve l s_of_ vi ta m in_ D _ are_ co r rel at ed _ with _ in cr e as ed _can c er_ risk ,_wh et he r _ th is _ rel ation sh ip _ is _caus al_ and_ vi ta m in_ D _ sup pl em en ta tion _ is _ pr ot e ctive_ is _ not_ de te r m in ed ._O ne _ 201 4 _ re vie w_ found_ that _ sup pl em ent s_ h ad _ no _ sign ific ant_ effect _ on _can c er_ risk ._A no ther_ 201 4 _ re vie w_ co n c lu de d_ that _ vi ta m in_ D 3 _m a y_ de cr e as e_the_ ris k_ of_ de at h_ fr om _can c er_ ( one_ fe we r _ de at h_ in_ 1 5 0_ peop le _ tr e at ed _ over _ 5_ year s ),_ but_ co n c er n s_ with _ the_ qu ality_ of_the_ d at a_ we re _ no te d .
B et a - C ar ot en e_ sup pl em en ta tion _ in cr e as es _ lung _can c er_ ra te s_in_ those_ who_ are_ high_ risk ._F ol ic_ ac id _ sup pl em en ta tion _ is _ not_ effect ive_ in_ pr ev ent ing _c olon _can c er_ and_ may_ in cr e as e_ co lo n_ po ly p s. _ S el en i um _ sup pl em en ta tion _ h as _ not_ been_ sh ow n_ to _ reduc e_the_ ris k_ of _can c er .

V acc in ation
V acc in es _ have_been_ de ve lo pe d_ that _ pr ev ent_ infect ion_ by_ som e_c arcin ogen ic_ vi r us es._ H um an_ pa p il lo ma vi r us _ v acc ine_ ( G ar d as il _and_ C erv ar ix )_ de cr e as e_the_ ris k_ of_ de ve lo p ing _c er vi c al _can c er ._The_ he pa t it is _ B _ v acc ine_ pr ev ent s_ infect ion_ with _ he pa t it is _ B _ vi r us _and_ th us _ de cr e as es _ the_ ris k_ of_ li ve r _can c er ._The_ ad m in is tr ation _of_ hum an_ pa p il lo ma vi r us _and_ he pa t it is _ B _ v acc in ations_ is _ re co m me n de d_ wh ere_ res ourc es _ al low .

S cr e en ing
Un like_ diag no st ic_ ef for t s_ pr om p te d_ by_ symp to m s_and_ me di c al_ sign s,_ c anc er_ screening_ inv ol ve s_ ef for t s_ to _ de te ct _can c er_ af te r _ it _ h as _ for me d ,_but_ be for e_ any_ not ic e ab le _ symp to m s_ appe ar ._Th is _m a y_ inv ol ve _ phys ical _ exam in ation,_ bl o od _or_ ur ine_ te st s_ or _m ed ical _ im ag ing .
C anc er_ screening_ is _ not_ av a il ab le _ for _m any_ typ es _ of _can c er s. _ E ve n_ when_ te st s_are_ av a il ab le ,_ they_ may_ not_ be _ re co m me n de d_ for _ ev er y on e. _ Un iv er s al_ screening_ or _m ass_ screening_ inv ol ve s_ screening_ ev er y on e. _ S el e ctive_ screening_ id ent if i es _ peop le _ who_ are_ at_ h ig he r _ risk ,_ su ch _ as _ peop le _ with _ a_ f am ily_ h is to r y. _ S ev er al_ fac to r s_are_ co n sid er ed _ to _ de te r m ine_ wh et he r _ the_ be ne f its_ of_ screening_ ou tw e igh_ the_ risk s_and_ the_ co st s_of_ screen ing ._These_ fac to r s_ include:

P os sib le _ har m s_ fr om _ the_ screening_ te st :_ for _ exam pl e,_ X - ra y_ im ag es _ inv ol ve _ expo su re _ to _ po te n t ia l ly _ har m ful _ ionizing_ radi ation
The_ lik eli ho od _of_ the_ te st _c or rect ly _ id ent if y ing _can c er
The_ lik eli ho od _ that _can c er_ is _ pr es ent :_ S cr e en ing_ is _ not_ no r ma l ly _ us ef ul _ for _ ra re _can c er s.
P os sib le _ har m s_ fr om _ fol low - up _ pr oc ed ur es
Wh et he r _ a_ su it ab le _ tr e at me n t_ is _ av a il ab le
Wh et he r _ ear ly _ de te ct ion_ im pr ov es _ tr e at me n t_ out co me s
Wh et he r _can c er_ wi l l _ ev er_ ne ed _ tr e at me n t
Wh et he r _ the_ te st_ is _ acc ep ta bl e_ to _ the_ peop le :_ I f_ a_ screening_ te st_ is _ to o_ bu r de n som e_ ( for _ exam pl e,_ ex tr em ely_ pa in ful ),_ th en_ peop le _ wi l l _ ref us e_ to _ pa r t ic ip at e.
C os t

R e co m me n d ation s
U . S ._P re ve n t ive_ S er vi c es _ T as k_ F or c e
The_ U . S ._P re ve n t ive_ S er vi c es _ T as k_ F or c e_ ( US P S T F )_ issu es _ re co m me n d ations_ for _ v ari ous_ cancer s :

St ro ng ly _ re co m me n d s_c er vi c al _can c er_ screening_ in_ wom en_ who_ are_ se x u al ly _ ac t ive_ and_ have_ a_ c er vi x _ at_ le as t_ un t il _ the_ age_ of_ 6 5 .
R e co m me n d_ that _ A me r ic an s_ be _ screen ed _ for _c ol or e ct al _can c er_ vi a_ fe c al_ oc cul t_ bl o od _ te st ing,_ s ig mo id os co p y, _ or _c olon os co p y_ st ar t ing_ at_ age_ 5 0_ un t il _ age_ 7 5 .
E vi de n c e_ is _ in suff ici ent_ to _ re co m me n d_ for _or_ again st_ screening_ for _ skin _can c er,_ or al _can c er,_ lung _can c er,_ or_ pr os ta te _can c er_ in _m en_ un de r _ 7 5 .
R out ine_ screening_ is _ not_ re co m me n de d_ for _ bl ad de r _can c er,_ te st icul ar _can c er,_ ov ar ia n_ c anc er,_ pa n cr e at ic _can c er,_ or_ pr os ta te _can c er .
R e co m me n d s_ ma m mo g ra ph y_ for _ bre as t_ c anc er_ screening_ ev er y_ tw o_ year s_ fr om _ ag es _ 5 0 – 7 4 ,_but_ do es _ not_ re co m me n d_ e it he r _ bre as t_ se l f - exam in ation_ or _c li n ical _ bre as t_ exam in ation ._A_ 201 3 _ C oc h ra ne _ re vie w_ co n c lu de d_ that _ bre as t_ c anc er_ screening_ by_ ma m mo g ra ph y_ h ad _ no _ effect _ in_ reduc ing _m or ta li t y_ becaus e_of_ over diagnos is _and_ over tr e at me n t .

J ap an
S cr e en s_ for _ g as tr ic _can c er_ us ing_ ph ot of lu or o g ra ph y_ du e_ to _ the_ high_ inc idenc e_ ther e.

G en etic _ te st ing
G en etic _ te st ing_ for _ indi vidu al s_ at_ high_ ris k_ of _certa in _can c ers_ is _ re co m me n de d_ by_ un of f ic ia l _ gro up s. _ C arr i ers_ of_ these_ mu ta tion s_ may_ th en_ un de r g o_ en h anc ed _ sur ve ill anc e,_ ch em op re ve n tion ,_ or_ pr ev en ta t ive_ surger y_ to _ reduc e_ their_ sub sequ ent_ risk .

M an ag em ent
M any_ tr e at me n t_ op tion s_ for _can c er_ ex is t ._The_ primary_ on es _ include _ surger y, _c he mo therap y, _ radiation_ therap y, _ ho r mo n al_ therap y, _ ta r get ed _ therap y_and_ pa l li ative_c ar e. _ Wh ic h_ tr e at me n t s_are_ us ed _ de pe n d s_ on_the_ typ e,_ loc ation _and_ g ra de _of_ the_c anc er_ as _ we l l _ as _ the_ pa t i ent 's_ heal th_ and_ pr ef er enc es._ The_ tr e at me n t_ in te n t_ may_ or _m a y_ not_ be _c ur ativ e.

Ch em ot he ra p y
Ch em ot he ra p y_ is _ the_ tr e at me n t_ of _can c er_ with _ one_ or _m ore_ c y to to x ic_ ant i - ne op l as t ic_ drug s_( ch em ot he ra pe ut ic_ agent s )_ as _ pa r t_of_ a_ st and ar di z ed _ reg im en ._The_ te r m _ en co mp as se s_ a_ v ari et y_of_ drug s,_which_ are_ di vi de d_ in to _ b ro ad _c at e g or i es _ su ch _ as _ al k yl ating_ agent s_and_ ant im et ab ol it es._ T radi tion al _c he mo therap e ut ic_ agent s_ ac t_ by_ k il li ng _cells_ that _ di vi de _ ra p id ly ,_ a_ cr it ical _ pr op er t y_ of _m os t_ cancer _cell s.
I t_ w as _ found_ that _ pr ov id ing _com bi ne d_ c y to to x ic_ drug s_ is _ be t te r _ than_ a_s ing le _ drug ,_ a_ pr oc ess_ c al le d_ the_ co m bi n ation_ therap y, _ which_ h as _ an_ adv an ta g e_ in_the_ stat is t ic s_of_ sur vi v al_ and_ res po n se _ to _ the_ tumor_ and_ in_the_ pr o g res s_of_ the_ diseas e. _ A_ C oc h ra ne _ re vie w_ co n c lu de d_ that _com bi ne d_ therapy_ w as _m ore_ effect ive_ in_ tr e at ing _m et as ta s iz ed _ bre as t_ cancer ._H ow ever,_ gener al ly _ it _ is _ not_ c erta in_ wh et he r _com bi n ation _c he mo therapy_ lead s_ to _ be t te r _ heal th_ out co me s,_ when_ bo th_ sur vi v al_ and_ to x ic ity_ are_ co n sid er ed .
T ar get ed _ therapy_ is _ a_ for m _ of _c he mo therapy_ that _ ta r get s_ spec ific _m ol e cul ar_ differ enc es _ be tw e en _can c er_ and_ no r ma l _cell s. _ The_ fir st_ ta r get ed _ therap i es _ bl oc k ed _ the_ es tr ogen _ rec ep to r _m ol e cul e,_ inhibit ing_the_ growth_ of_ bre as t_ cancer ._A no ther _com mo n_ exam pl e_ is _ the_c l ass_ of_ B cr - A bl _ inhibit or s,_which_ are_ us ed _ to _ tr e at _ch ro n ic _m y el ogen ous_ leuk em ia _ ( C M L ) ._C ur re n t ly ,_ ta r get ed _ therap i es _ ex is t_ for _m any_ of_the_ most _com mo n_ c anc er_ typ es,_ inclu di ng _ bl ad de r _can c er,_ bre as t_ c anc er,_ co lo rect al _can c er,_ k id ne y_ c anc er,_ leuk em ia ,_ li ve r _can c er,_ lung _can c er,_ lymp ho ma ,_ pa n cr e at ic _can c er,_ pr os ta te _can c er,_ skin _can c er,_ and_ th y ro id _can c er_ as _ we l l _ as _ ot he r _can c er_ typ es.
The_ ef f ic ac y_ of _c he mo therapy_ de pe n d s_ on_the_ typ e_ of _can c er_ and_ the_ stag e. _ In _com bi n ation_ with _ surger y, _c he mo therapy_ h as _ pr ov en_ us ef ul _ in _can c er_ typ es _ inclu di ng _ bre as t_ c anc er,_ co lo rect al _can c er,_ pa n cr e at ic _can c er,_ os te ogen ic_ s ar co ma ,_ te st icul ar _can c er,_ ov ar ia n_ c anc er_ and_c erta in_ lung _can c er s. _ Ch em ot he ra p y_ is _c ur ativ e_ for _ som e_cancer s,_ su ch _ as _ som e_ leuk em ia s,_ in effect ive_ in_ som e_ bra in_ tumor s,_ and_ ne ed le s s_in_ ot he r s,_ su ch _ as _m os t_ no n - me l an oma_ skin _can c er s. _ The_ effect iv en ess_ of _c he mo therapy_ is _ of te n_ li m it ed _ by_ its_ to x ic ity_ to _ ot he r _ tissu es _ in_the_ bo d y. _ E ve n_ wh en _c he mo therapy_ do es _ not_ pr ov ide_ a_ pe r ma ne n t_ cur e,_ it _m a y_ be _ us ef ul _ to _ reduc e_ symp to m s_ su ch _ as _ pa in_ or_ to _ reduc e_the_ s iz e_of_ an_ in op er ab le _ tumor_ in_the_ ho pe _ that _ surger y_ wi l l _ be co me _ po s sib le _ in_the_ f ut ur e.

Radi ation
Radiation_ therapy_ inv ol ve s_ the_ us e_of_ ionizing_ radiation_ in_ an_ at te mp t_ to _ e it he r _c ure_ or_ im pr ov e_ symp to m s. _ I t_ wor k s_ by_ damag ing_the_ DNA_ of _can c er ous_ tissu e,_ caus ing _m it ot ic _c at as tr op he _ result ing_ in_the_ de at h_ of_the_ cancer _cell s. _ T o_ s pa re _ no r ma l _ tissu es _ ( su ch _ as _ skin _or_ org ans ,_wh ic h_ radi ation _m us t_ pa s s_ through_ to _ tr e at_ the_ tumor ),_ sh ap ed _ radiation_ be am s_are_ a im ed _ fr om _m ult ip le _ expo su re _ ang le s_ to _ in te r se ct _ at_ the_ tumor ,_ pr ov id ing_ a_ mu ch _ lar ger _ do se _ there_ than_ in_the_ sur ro un di ng ,_ health y_ tissu e. _ A s_ with _c he mo therap y, _can c ers_ v ary_ in_ their_ res po n se _ to _ radiation_ therap y.
Radiation_ therapy_ is _ us ed _ in_ about_ h al f_ of _cas es._ The_ radi ation _can _ be _ e it he r _ fr om _ in te r n al_ sourc es _ ( bra ch y therapy )_ or_ ex te r n al_ sourc es._ The_ radiation_ is _m os t_ co m mo n ly _ lo w_ energy_ X - ra ys _ for _ tr e ating_ skin _can c er s,_ wh ile_ h ig he r _ energy_ X - ra ys _ are_ us ed _ for _can c ers_ with in_the_ bo d y. _ Radiation_ is _ typ ical ly _ us ed _ in_ ad dit ion_ to _ surger y_ and / or _c he mo therap y. _ F or _certa in_ typ es _ of _can c er,_ su ch _ as _ ear ly _ he ad _and_ ne c k_ c anc er,_ it _m a y_ be _ us ed _ al on e. _ Radiation_ therapy_ af te r _ surger y_ for _ bra in _m et as ta se s_ h as _ been_ sh ow n_ to _ not_ im pr ov e_ over all_ sur vi v al_ in_ pa t i ent s_ co mp ar ed _ to _ surger y_ al on e. _ F or_ pa in ful _ bo ne _m et as ta s is,_ radiation_ therapy_ h as _ been_ found_ to _ be _ effect ive_ in_ about_ 7 0 %_of _ pa t i ent s.

S ur ger y
S ur ger y_ is _ the_ primary_ meth od _of_ tr e at me n t_ for _m os t_ is ol at ed ,_ s ol id _can c ers_ and_ may_ pla y_ a_ ro le _ in_ pa l li ation _and_ pr olon g ation _of_ sur vi v al ._I t_ is _ typ ical ly _ an_ im po r ta n t_ pa r t_of_ the_ def init ive_ diagnos is _and_ stag ing_ of_ tumor s,_ as _ bi op s i es _ are_ us u al ly _ requ ir ed ._ In _ loc al iz ed _can c er,_ surger y_ typ ical ly _ at te mp t s_ to _ re mo ve _ the_ ent ir e_ ma s s_ al ong_ with ,_ in _certa in _cas es,_ the_ lymp h_ no de s_in_ the_ ar e a ._For_ som e_ typ es _ of _can c er_ th is _ is _ suff ici ent_ to _ el im in ate_ the_c ancer .

P al li ative_c ar e
P al li ative_c are_ is _ tr e at me n t_ that _ at te mp t s_ to _ he l p _ the_ pa t i ent_ fe el _ be t te r _and_ may_ be _com bi ne d_ with _ an_ at te mp t_ to _ tr e at_ the_c ancer ._P al li ative_c are_ include s_ ac tion _ to _ reduc e_ phys ical ,_ em ot ion al ,_ s p ir it u al_ and_ p sy ch o - s oc ia l _ di st res s. _ Un like_ tr e at me n t_ that _ is _ a im ed _ at_ di rect ly _ k il li ng _can c er _cell s,_ the_ primary_ g o al_ of_ pa l li ative_c are_ is _ to _ im pr ov e_ qu ality_ of_ life .
P e op le _ at_ all_ stag es _ of _can c er_ tr e at me n t_ typ ical ly _ rec e ive_ som e_ kin d_ of_ pa l li ative_c ar e. _ In _ som e_c as es,_ me di c al_ spec ia l t y_ pr of ess ion al_ org an iz ations_ re co m me n d_ that _ pa t i ent s_and_ phys ic ia n s_ res po n d_ to _can c er_ on ly _ with _ pa l li ative_c ar e. _ Th is _ ap pl i es _ to _ pa t i ent s_ wh o :

Di s pla y_ lo w_ pe r for ma n c e_ stat us,_ im pl y ing_ li m it ed _ abil ity_ to _c are_ for _ th em se l ve s
R e c e iv ed _ no _ be ne f it _ fr om _ pr i or_ ev idenc e- b as ed _ tr e at me n t s
A re _ not_ el ig ib le _ to _ pa r t ic ip ate_ in_ any_ ap pr op r ia te _c li n ical _ tr ia l
N o_ st ro ng _ ev idenc e_ im pl i es _ that _ tr e at me n t_ would_ be _ effect iv e
P al li ative_c are_ may_ be _con f us ed _ with _ ho s p ic e_and_ ther ef ore_ on ly _ indi c at ed _ when_ peop le _ ap pr o ach_ end_ of_ life ._ L i ke_ ho s p ic e_c ar e,_ pa l li ative_c are_ at te mp t s_ to _ he l p _ the_ pa t i ent_ co pe _ with _ their_ im me di ate_ ne ed s_and_ to _ in cr e as e_ co m for t ._ Un like_ ho s p ic e_c ar e,_ pa l li ative_c are_ do es _ not_ requ ir e_ peop le _ to _ st op _ tr e at me n t_ a im ed _ at_ the_c ancer .
M ult ip le _ n ation al _m ed ical _ g u id el in es _ re co m me n d_ ear ly _ pa l li ative_c are_ for _ pa t i ent s_ wh ose_ c anc er_ h as _ pr od u c ed _ di st ress ing_ symp to m s_or_ who_ ne ed _ he l p _c op ing_ with _ their_ ill ne s s. _ In _ pa t i ent s_ fir st_ diag no se d_ with _m et as ta t ic_ diseas e,_ pa l li ative_c are_ may_ be _ im me di ately_ indi c at ed ._P al li ative_c are_ is _ indi c at ed _ for _ pa t i ent s_ with _ a_ pr o gn os is _of_ le s s_ than_ 1 2 _m on th s_of_ life _ ev en_ g iv en_ ag g ress ive_ tr e at me n t .

I m mu no therapy
A_ v ari et y_of_ therap i es _ us ing_ im mu no therap y, _ st im ul ating_ or_ he l p ing_the_ im mu ne _ system _ to _ f ight_ c anc er,_ have_ co me _ in to _ us e_ s inc e_ 19 9 7 ._A p pr o ac he s_ include:

M on oc lo n al_ ant ib od y_ therapy
Ch e c k po in t_ therapy_ ( therapy_ that _ ta r get s_ the_ im mu ne _c he c k po in t s_or_ reg ul at ors_ of_the_ im mu ne _ system )
A do p t ive_ c ell_ trans fe r
C A R _ T _cell

L as er_ therapy
L as er_ therapy_ us es _ high -in te n sit y_ li g h t_ to _ tr e at _can c er_ by_ sh r in kin g _or_ de st ro y ing_ tum ors_ or_ pr e cancer ous_ grow th s. _ L as ers_ are_ most _com mo n ly _ us ed _ to _ tr e at_ su pe r f ic ia l _can c ers_ that _ are_ on_the_ sur fac e_of_the_ bo d y_ or_ the_ li n ing_ of_ in te r n al_ org an s. _ I t_ is _ us ed _ to _ tr e at_ b as al _cell_ skin _can c er_ and_ the_ ve r y_ ear ly _ stag es _of_ ot he r s_ lik e_c er vi c al ,_ pe n il e,_ v ag in al ,_ v ul v ar ,_and_ no n - s ma l l _cell_ lung _can c er ._I t_ is _ of te n_ co m bi ne d_ with _ ot he r _ tr e at me n t s,_ su ch _ as _ surger y, _c he mo therap y, _or_ radiation_ therap y. _ L as er -in duc ed _ in te r st it ia l _ ther mo therapy_ ( L I T T ),_ or_ in te r st it ia l _ l as er_ ph ot oc o ag ul ation,_ us es _ l as ers_ to _ tr e at_ som e_c anc ers_ us ing_ hyper ther m ia ,_wh ic h_ us es _ he at_ to _ sh r in k_ tum ors_ by_ damag ing_ or_ k il li ng _can c er _cell s. _ L as er_ are_ mo re _ pr e c is e_ than_ surger y_and_ caus e_ le s s_ damag e,_ pa in ,_ bl e ed ing,_ s we l li ng ,_and_ sc arr ing ._A_ dis adv an ta g e_ is _ that _ sur g e on s_ mu st_ have_ spec ia li z ed _ tr ain ing ._I t_ may_ be _m ore_ ex pe n s ive_ than_ ot he r _ tr e at me n t s.

A l te r n ativ e_ me di c in e
C om pl em en ta r y_and_ al te r n ative_c anc er_ tr e at me n t s_are_ a_ di ve r se _ gro up _of_ therap i es,_ pr ac t ic es _and_ pr od u ct s_ that _ are_ not_ pa r t_ of _con ve n tion al _m ed ic in e. _ " C om pl em en ta r y_ me di c in e "_ re fe r s_ to _m et ho d s_and_ substanc es _ us ed _ al ong_ with _con ve n tion al _m ed ic in e,_ wh ile_ " al te r n ativ e_ me di c in e "_ re fe r s_ to _com po und s_ us ed _ in st e ad _ of _con ve n tion al _m ed ic in e. _ M os t_ co mp le me n ta r y_and_ al te r n ativ e_ me di c in es _ for _can c er_ have_ not_ been_ studi ed _or_ te st ed _ us ing _con ve n tion al_ te ch n i qu es _ su ch _ as _c li n ical _ tr ia l s. _ Some_ al te r n ativ e_ tr e at me n t s_ have_been_ in ve st ig at ed _and_ sh ow n_ to _ be _ in effect ive_ but_ st ill _con t in u e_ to _ be _m ar k et ed _and_ pr om ot ed ._C anc er_ rese ar ch er_ A n dr e w_ J ._ V ic k ers_ stat ed ,_ " The_ l ab el _ ' un pr ov en ' _ is _ in ap pr op r ia te _ for _ su ch _ therap i es ;_ it _ is _ tim e_ to _ as se r t_ that _m any_ al te r n ative_c anc er_ therap i es _ have_been_ ' dis pr ov en ' . "

P ro gn os is
S ur vi v al_ ra te s_ v ary_ by_ c anc er_ typ e_and_ by_ the_ stag e_ at_ which_ it _ is _ diag no se d ,_ ra ng ing_ fr om _m a j or ity_ sur vi v al_ to _com pl et e_ mo r ta li t y_ f ive_ year s_ af te r _ diagnos is ._O n c e_ a_ c anc er_ h as _m et as ta s iz ed ,_ pr o gn os is _ no r ma l ly _ be co me s_ mu ch _ wor se ._A bo ut _ h al f_ of_ pa t i ent s_ rec e iv ing_ tr e at me n t_ for _ invas ive_ c anc er_ ( exc lu di ng _carcin oma_ in_ sit u _and_ no n - me l an oma_ skin _can c er s )_ di e_ fr om _ that _can c er_ or_ its_ tr e at me n t ._A_ maj or ity_ of _can c er_ de at h s_are_ du e_ to _m et as ta se s_of_ the_ primary_ tumor .
S ur vi v al_ is _ wor se _ in_the_ de ve lo p ing_ world ,_ pa r t ly _ becaus e_the_ typ es _ of _can c er_ that _ are_ most _com mo n_ there_ are_ har de r _ to _ tr e at_ than_ those_ ass oc ia te d_ with _ de ve lo pe d_ co un tr i es.
Th ose_ who_ sur vi ve _can c er_ de ve lo p _ a_ se co n d_ primary_ c anc er_ at_ about_ tw ic e_the_ ra te _of_ those_ ne ve r _ diag no se d ._The_ in cr e as ed _ ris k_ is _ be li ev ed _ to _ be _ du e_ to _ the_ ra n do m _ch anc e_of_ de ve lo p ing_ any_ c anc er,_ the_ lik eli ho od _of_ sur vi vi ng _ the_ fir st _can c er,_ the_s ame_ ris k_ fac to r s_ that _ pr od u c ed _ the_ fir st _can c er,_ un w an te d_ sid e_ effect s_of_ tr e ating_ the_ fir st _can c er_ ( pa r t icul ar ly _ radiation_ therapy ),_ and_ be t te r _com pl ia n c e_ with _ screen ing .
P re di ct ing_ sh or t - _or_ lo ng - te r m _ sur vi v al_ de pe n d s_ on _m any_ fac to r s. _ The_ most_ im po r ta n t_ are_ the_c anc er_ typ e_and_ the_ pa t i ent 's_ age_ and_ over all_ health ._Th ose_ who_ are_ fr a il _ with _ ot he r _ heal th_ pr ob le m s_ have_ lo we r _ sur vi v al_ ra te s_ than_ ot he r wi se _ health y_ peop le ._C en te n ar ia n s_are_ un lik ely_ to _ sur vi ve _ for _ f ive_ year s_ ev en_ if_ tr e at me n t_ is _ su cc ess ful ._P e op le _ who_ re po r t_ a_ h ig he r _ qu ality_ of_ life _ te n d_ to _ sur vi ve _ lo ng er ._P e op le _ with _ lo we r _ qu ality_ of_ life _m a y_ be _ affect ed _ by_ de pr ess ion_ and_ ot he r _com plic ations_ and / or_ disease_ pr o g ress ion_ that _ bo th_ im pa ir s_ qu ality_ and_ qu ant ity_ of_ life ._A d dit ion al ly ,_ pa t i ent s_ with _ wor se _ pr o gn os es _m a y_ be _ de pr es se d_ or_ re po r t_ po or er_ qu ality_ of_ life _ becaus e_ they_ pe r c e ive_ that _ the ir _con dit ion_ is _ lik ely_ to _ be _ f at al .
P e op le _ with _can c er_ have_ an_ in cr e as ed _ ris k_ of_ bl o od _c lo t s_in_ their_ ve in s_ which_ c an_ be _ life - th reat en ing ._The_ us e_of_ bl o od _ th in ne r s_ su ch _ as _ he pa r in_ de cr e as e_the_ ris k_ of_ bl o od _c lo t s_ but_ have_ not_ been_ sh ow n_ to _ in cr e as e_ sur vi v al_ in_ peop le _ with _can c er ._P e op le _ who_ ta ke_ bl o od _ th in ne r s_ also_ have_ an_ in cr e as ed _ ris k_ of_ bl e ed ing .
A l thoug h_ ex tr em ely_ ra re ,_ som e_ for m s_ of _can c er,_ ev en_ fr om _ an_ advanc ed _ stag e,_ c an_ heal _ s po n ta ne ou s ly ._Th is _ ph en om en on_ is _ known_ as _ s po n ta ne ous_ re mis s ion .

Ep id emi ol o g y
E st im at es _ are_ that _ in_ 201 8 ,_ 1 8 . 1 _m il li on_ ne w_ c as es _ of _can c er_ and_ 9 . 6 _m il li on_ de at h s_ occur_ g lo b al ly ._A bo ut _ 20 %_of _m al es _and_ 1 7 %_of _ fe ma le s_ wi l l _ get _can c er_ at_ som e_ po in t_ in_ tim e_ wh ile_ 1 3 %_of _m al es _and_ 9 %_of _ fe ma le s_ wi l l _ di e_ fr om _ it .
In _ 20 0 8 ,_ ap pr ox im ately_ 1 2 . 7 _m il li on _can c ers_ we re _ diag no se d_ ( exc lu di ng _ no n - me l an oma_ skin _can c ers_ and_ ot he r _ no n -in v as ive_ cancer s )_ and_ in_ 20 10 _ ne ar ly _ 7 . 9 8 _m il li on_ peop le _ di ed ._C anc ers_ ac co un t_ for _ al most_ one_ in_ s ix _ de at h s. _ The_ c anc ers_ caus ing_the_ most_ de at h s,_ as _of_ 20 20 _ are_ lung _can c er_ ( 1. 8 _m il li on ),_ co lo rect al _can c er_ ( 9 16 ,00 0 ),_ li ve r _can c er_ ( 8 3 0 ,00 0 ),_ st om ach_ c anc er_ ( 7 6 9 ,00 0 )_ and_ bre as t_ c anc er_ ( 6 8 5 ,00 0 ) ._Th is _m a k es _ invas ive_ c anc er_ the_ lead ing _caus e_of_ de at h_ in_the_ de ve lo pe d_ wor ld_ and_ the_ se co n d_ lead ing_ in_the_ de ve lo p ing_ world ._O ve r _ h al f_ of_ these_ c as es _ occur_ in_the_ de ve lo p ing_ world .
D e at h s_ fr om _can c er_ we re _ 5 . 8 _m il li on_ in_ 19 9 0 ._ D e at h s_ have_been_ in cr e as ing_ prim ar ily_ du e_ to _ lo ng er_ life s pa n s_and_ life st yl e_ ch ang es _ in_the_ de ve lo p ing_ world ._The_ most_ sign ific ant_ ris k_ fac to r _ for _ de ve lo p ing _can c er_ is _ ag e. _ A l thoug h_ it _ is _ po s sib le _ for _can c er_ to _ str i ke_ at_ any_ ag e,_ most_ pa t i ent s_ with _ invas ive_ c anc er_ are_ over _ 6 5 ._A cc or di ng _ to _can c er_ rese ar ch er_ R ob er t_ A ._ W e in be r g ,_ " I f_ we _ li ve d_ lo ng _ en oug h ,_ s o on er_ or_ l at er_ we _ all_ would_ get _can c er . "_ Some_ of_the_ ass oc ia tion _ be tw e en_ aging_ and_c anc er_ is _ at tr ibut ed _ to _ im mu no se ne sc enc e,_ er ro r s_ acc um ul at ed _ in_ DNA_ over _ a_ life tim e_and_ ag e- rel at ed _ch ang es _ in_the_ en do cr ine_ system ._A g ing 's_ effect _ on _can c er_ is _com plic at ed _ by_ fac to r s_ su ch _ as _ DNA_ dam age_ and_ in f lam ma tion _ pr om ot ing_ it _and_ fac to r s_ su ch _ as _ v as cul ar_ aging_ and_ en do cr ine_ ch ang es _ inhibit ing_ it .
Some_ s low - gro wi ng _can c ers_ are_ pa r t icul ar ly _com mo n ,_but_ of te n_ are_ not_ f at al ._A ut op sy _ studi es _ in_ E ur op e_and_ A s ia _ sh ow ed _ that _ up _ to _ 3 6 %_of _ peop le _ have_ un diag no se d_ and_ ap pa re n t ly _ har m le s s_ th y ro id _can c er_ at_ the_ tim e_of_ their_ de at h s_and_ that _ 8 0 %_of _m en_ de ve lo p _ pr os ta te _can c er_ by_ age_ 8 0 ._A s_ these_ c anc ers_ do _ not_ caus e_the_ pa t i ent 's_ de at h ,_ id ent if y ing_ th em _ would_ have_ re pr es en te d_ over diagnos is _ rather_ than_ us ef ul _m ed ical _c ar e.
The_ th ree_ most _com mo n_ ch il d ho od _can c ers_ are_ leuk em ia _ ( 3 4 % ),_ bra in_ tum ors_ ( 2 3 % )_ and_ lymp ho ma s_( 1 2 % ) ._ In _ the_ Un it ed _ St at es _can c er_ affect s_ about_ 1 _ in_ 2 8 5_ ch il dr en ._ Ra te s_ of _chil d ho od _can c er_ in cr e as ed _ by_ 0 . 6 %_ pe r _ year _ be tw e en_ 19 7 5_ and_ 20 0 2 _ in_the_ Un it ed _ St at es _and_ by_ 1. 1 %_ pe r _ year _ be tw e en_ 19 7 8 _and_ 19 9 7 _ in_ E ur op e. _ D e at h_ fr om _chil d ho od _can c er_ de cr e as ed _ by_ h al f_ be tw e en_ 19 7 5_ and_ 20 10 _ in_the_ Un it ed _ St at es.

H is to r y
C anc er_ h as _ ex is te d_ for _ all_ of_ hum an_ h is to r y. _ The_ ear li es t_ w r it te n_ re co r d_ reg ar di ng _can c er_ is _ fr om _c .   16 00 _ B C _ in_the_ E g yp t ia n_ E d wi n_ S m it h_ P ap y r us _and_ de sc r ib es _ bre as t_ cancer ._H ip po cr at es _ ( c .   4 6 0_ B C _ – _c .   3 7 0_ B C )_ de sc r ib ed _ se ve ra l _ kin d s_ of _can c er,_ re fe r r ing_ to _ th em _ with _ the_ G re e k_ wor d_ κ α ρ κ ί ν ο ς _ k ar kin os _ ( cr ab _ or _c ra y f is h ) ._Th is _ n ame_ co me s_ fr om _ the_ appe ar anc e_of_ the_c ut _ sur fac e_of_ a_s ol id _m al ign ant_ tumor ,_ with _ " the_ ve in s_ st re t ch ed _ on_ all_ sid es _ as _ the_ anim al_ the_ cr ab _ h as _ its_ fe et ,_wh enc e_ it _ de r iv es _ its_ n am e " ._ G al en_ stat ed _ that _ " c anc er_ of_the_ bre as t_ is _ s o_ c al le d_ becaus e_of_the_ f anc i ed _ rese m bl anc e_ to _ a_ cr ab _ g iv en_ by_ the_ l at er al_ pr olon g ation s_of_ the_ tumor_ and_ the_ ad j ac ent_ di st en de d_ ve in s " ._C el su s_( c .   2 5_ B C _ – _ 5 0_ A D )_ trans l at ed _ k ar kin os _ in to _ L at in_ as _can c er,_ also_ me an ing _c ra b _and_ re co m me n de d_ surger y_ as _ tr e at me n t ._ G al en_ ( 2 n d_ c ent ur y_ A D )_ dis ag re ed _ with _ the_ us e_of_ surger y_and_ re co m me n de d_ p ur g ativ es _ in st e ad ._These_ re co m me n d ations_ lar g ely_ st o od _ for _ 10 00 _ year s.
In _ the_ 1 5 th ,_ 16 th_ and_ 1 7 th _c ent ur i es,_ it _ be c ame_ acc ep ta bl e_ for _ do ct ors_ to _ dis se ct _ bo di es _ to _ disc over _ the_c aus e_of_ de at h ._The_ G er ma n_ pr of ess or_ W il he l m _ F ab r y_ be li ev ed _ that _ bre as t_ c anc er_ w as _caus ed _ by_ a_ m il k_ c lo t_ in_ a_ ma m ma r y_ duct ._The_ D ut ch _ pr of ess or_ F ra n co is _ de _ l a_ B o e_ S yl vi us,_ a_ fol lo we r _of_ D es c ar te s,_ be li ev ed _ that _ all_ disease_ w as _ the_ out co me _ of _c he mic al_ pr oc es se s_and_ that _ ac id ic_ lymp h_ f lu id _ w as _ the_c aus e_ of _can c er ._H is _con te mp or ary_ N ic ol a es _ T ul p _ be li ev ed _ that _can c er_ w as _ a_ po is on_ that _ s low ly _ s pr e ad s_and_ co n c lu de d_ that _ it _ w as _con ta g i ou s.
The_ phys ic ia n_ J o h n_ H ill_ de sc r ib ed _ tob ac co _ s n if f ing_ as _ the_c aus e_of_ no se _can c er_ in_ 1 7 6 1. _ Th is _ w as _ fol lo we d_ by_ the_ re po r t_ in_ 1 7 7 5_ by_ B r it is h_ sur g e on_ P er c iv all_ P ot t_ that _ch im ne y_ s we ep s ' _carcin oma,_ a_ c anc er_ of_the_ sc ro tum ,_ w as _ a_ co m mo n_ disease_ am ong _ch im ne y_ s we ep s. _ W it h_ the_ wi de s pr e ad _ us e_of_the_ mic ro sc op e_ in_the_ 1 8 th _c ent ur y, _ it _ w as _ disc over ed _ that _ the_ ' c anc er_ po is on ' _ s pr e ad _ fr om _ the_ primary_ tumor_ through_ the_ lymp h_ no de s_ to _ ot he r _ sit es _ ( " me ta st as is " ) ._Th is _ vie w_ of_the_ disease_ w as _ fir st_ for mu l at ed _ by_ the_ E ng li sh _ sur g e on_ C am p be l l _ D e_ M org an_ be tw e en_ 1 8 7 1 _and_ 1 8 7 4 .

S oci et y_and_ cul t ur e
A l thoug h_ ma n y_ diseas es _ ( su ch _ as _ he ar t_ f a il ur e )_ may_ have_ a_ wor se _ pr o gn os is _ th an _m os t_ c as es _ of _can c er,_ c anc er_ is _ the_ sub j e ct _of_ wi de s pr e ad _ fe ar_ and_ ta bo os ._The_ e up he mis m _of_ " a_ lo ng _ ill ne s s "_ to _ de sc r ib e_c anc ers_ lead ing_ to _ de at h_ is _ st ill _com mo n ly _ us ed _ in_ ob it u ari es,_ rather_ than_ n am ing_the_ disease_ ex plic it ly ,_ ref le ct ing_ an_ ap pa re n t_ st ig ma ._C anc er_ is _ also_ e up he mis ed _ as _ " the_ C - wor d " ;_ M ac m ill an_ C anc er_ S up po r t_ us es _ the_ te r m _ to _ tr y_ to _ le s se n_ the_ fe ar_ around_ the_ diseas e. _ In _ N ig er ia ,_ one_ loc al_ n ame_ for _can c er_ trans l at es _ in to _ E ng li sh _ as _ " the_ disease_ that _can not_ be _c ur ed " ._Th is _ de ep _ be li ef _ that _can c er_ is _ ne c ess ar ily_ a_ diff icul t_ and_ us u al ly _ de ad ly _ disease_ is _ ref le ct ed _ in_the_ system s_ ch os en_ by_ s oci et y_ to _com p ile_ c anc er_ stat is t ic s :_ the_ most _com mo n_ for m _ of _can c er — no n - me l an oma_ skin _can c er s,_ ac co un t ing_ for _ about_ on e- th ir d_ of _can c er _cas es _ world wi de ,_but_ ve r y_ fe w_ de at h s — are_ exc lu de d_ fr om _can c er_ stat is t ic s_ spec ific al ly _ becaus e_ they_ are_ e as ily_ tr e at ed _and_ al most_ al w a ys _c ur ed ,_ of te n_ in_ a_s ing le ,_ sh or t ,_ out pa t i ent_ pr oc ed ur e.
W es te r n_ co n c ep tion s_of_ pa t i ent s ' _ r ight s_ for _ peop le _ with _can c er_ include _ a_ du t y_ to _ ful ly _ disc lo se _ the_ me di c al_ sit u ation_ to _ the_ pe r s on ,_and_ the_ r ight_ to _ en g age_ in_ sh ar ed _ dec is ion - ma kin g _ in_ a_ w a y_ that _ res pe ct s_ the_ pe r s on 's_ ow n_ v al u es._ In _ ot he r _c ult ur es,_ ot he r _ r ight s_and_ v al u es _ are_ pr ef er re d ._For_ exam pl e,_ most_ A fr ic an _c ult ur es _ v al u e_ wh ol e_ f am il i es _ rather_ than_ indi vidu al ism ._ In _ pa r t s_of_ A fr ic a ,_ a_ diagnos is _ is _com mo n ly _m ad e_ s o_ l ate_ that _c ure_ is _ not_ po s sib le ,_and_ tr e at me n t ,_ if_ av a il ab le _ at_ all ,_ would_ qu ic k ly _ b an k r up t_ the_ f am il y. _ A s_ a_ resul t_of_ these_ fac to r s,_ A fr ic an_ health c are_ pr ov id ers_ te n d_ to _ le t_ f am ily_ me m be r s_ dec ide_ wh et he r ,_wh en_ and_ ho w_ to _ disc lo se _ the_ diagnos is,_ and_ they_ te n d_ to _ do _ s o_ s low ly _and_ c ir c u it ou s ly ,_ as _ the_ pe r s on_ sh ow s_ in te re st_ and_ an_ abil ity_ to _c op e_ with _ the_ g r im _ ne w s. _ P e op le _ fr om _ A s ia n_ and_ S ou th_ A me r ic an _c ountr i es _ also_ te n d_ to _ pr ef er_ a_s lo we r ,_ le s s_c an di d_ ap pr o ach_ to _ disc lo su re _ than_ is _ id e al iz ed _ in_the_ Un it ed _ St at es _and_ W es te r n_ E ur op e,_ and_ they_ be li ev e_ that _ som et im es _ it _ would_ be _ pr ef er ab le _ not_ to _ be _ to ld_ about_ a_ c anc er_ diagnos is ._ In _ gener al ,_ disc lo su re _of_ the_ diagnos is _ is _m ore_ co m mo n_ than_ it _ w as _ in_the_ 20 th _c ent ur y, _ but_ ful l _ disc lo su re _of_ the_ pr o gn os is _ is _ not_ of fe red_ to _m any_ pa t i ent s_ around_ the_ world .
In _ the_ Un it ed _ St at es _and_ som e_ ot he r _c ult ur es,_ c anc er_ is _ reg ar de d_ as _ a_ disease_ that _m us t_ be _ " f oug h t "_ to _ end_ the_ " c iv il _ in sur rect ion " ;_ a_ w ar_ on _can c er_ w as _ dec lar ed _ in_the_ US ._M il it ary_ me ta ph ors_ are_ pa r t icul ar ly _com mo n_ in_ de sc r ip tion s_ of _can c er 's_ hum an_ effect s,_ and_ they_ em ph as iz e_ bo th_ the_ stat e_of_the_ pa t i ent 's_ heal th_ and_ the_ ne ed _ to _ ta ke_ im me di at e,_ dec is ive_ ac tion s_ h im se l f_ rather_ than_ to _ de l a y, _ to _ ig no re _or_ to _ re ly _ ent ir ely_ on_ ot he r s. _ The_ m il it ary_ me ta ph ors_ also_ he l p _ ra tion al iz e_ radi c al ,_ de str u ctive_ tr e at me n t s.
In _ the_ 19 7 0 s,_ a_ rel ativ ely_ po p ul ar_ al te r n ative_c anc er_ tr e at me n t_ in_the_ US _ w as _ a_s pec ia li z ed _ for m _of_ ta l k_ therap y, _ b as ed _ on_the_ id e a_ that _can c er_ w as _caus ed _ by_ a_ b ad _ att it u de ._P e op le _ with _ a_ " c anc er_ pe r s on al it y " — de pr es se d ,_ re pr es se d ,_ se l f - lo at h ing_ and_ af ra id _ to _ ex pr ess_ their_ em ot ion s — we re _ be li ev ed _ to _ have_ ma n if es te d_ c anc er_ through_ sub co n sc ious_ de s ir e. _ Some_ p sy ch ot he ra p is t s_c l a im ed _ that _ tr e at me n t_ to _ch ang e_the_ pa t i ent 's_ out lo o k_ on_ life _ would_ cur e_the_ cancer ._A mo ng _ ot he r _ effect s,_ th is _ be li ef _ al lo we d_ s oci et y_ to _ bl ame_ the_ vi ct im _ for _ hav ing _caus ed _ the_c anc er_ ( by_ " w ant ing "_ it )_ or_ hav ing_ pr ev en te d_ its_ cur e_ ( by_ not_ be co m ing_ a_ suff ici ent ly _ h ap p y, _ fe ar le s s_and_ lo vi ng _ pe r s on ) ._I t_ also_ in cr e as ed _ pa t i ent s ' _ an x i et y, _ as _ they_ in co r rect ly _ be li ev ed _ that _ n at ur al_ em ot ion s_of_ s ad ne s s,_ ang er_ or_ fe ar_ sh or te n_ their_ li ve s. _ The_ id e a_ w as _ r id icul ed _ by_ S us an_ S on ta g ,_wh o_ p u bl is he d_ I l l ne s s_ as _ Met ap ho r _ wh ile_ re co ve r ing_ fr om _ tr e at me n t_ for _ bre as t_ c anc er_ in_ 19 7 8 ._A l thoug h_ the_ orig inal_ id e a_ is _ no w_ gener al ly _ reg ar de d_ as _ no n se n se ,_ the_ id e a_ pa r t ly _ pe r s is t s_in_ a_ reduc ed _ for m _ with _ a_ wi de s pr e ad ,_but_ in co r rect ,_ be li ef _ that _ de li be ra te ly _c ult iv ating_ a_ h ab it _of_ po sit ive_ th in kin g _ wi l l _ in cr e as e_ sur vi v al ._Th is _ not ion_ is _ pa r t icul ar ly _ st ro ng _ in_ bre as t_ cancer _c ult ur e.
O ne _ id e a_ about_ wh y_ peop le _ with _can c er_ are_ bl am ed _or_ st ig ma t iz ed ,_ c al le d_ the_ j us t - wor ld_ f all ac y, _ is _ that _ bl am ing _can c er_ on_the_ pa t i ent 's_ ac tion s_or_ att it u de s_ al low s_ the_ bl am ers_ to _ reg ain _ a_ se n se _ of _con tr ol ._Th is _ is _ b as ed _ up on_the_ bl am er s ' _ be li ef _ that _ the_ wor ld_ is _ f und am en ta l ly _ j us t_ and_ s o_ any_ d ang er ous_ ill ne s s,_ lik e_c anc er,_ mu st_ be _ a_ typ e_of_ p un is h me n t_ for _ b ad _c ho ic es,_ becaus e_ in_ a_ j us t_ world ,_ b ad _ th ing s_ would_ not_ h appe n_ to _ g o od _ peop le .

E co no mic _ effect
The_ to ta l _ health _c are_ ex pe n dit ure_ on _can c er_ in_the_ US _ w as _ es tim at ed _ to _ be _ $ 8 0 . 2 _ bi l li on_ in_ 201 5 ._E ve n_ thoug h_ cancer - rel at ed _ health _c are_ ex pe n dit ure_ have_ in cr e as ed _ in_ ab s ol ut e_ te r m s_ dur ing_ rec ent_ dec ad es,_ the_ sh are_ of_ heal th_ ex pe n dit ure_ de v ot ed _ to _can c er_ tr e at me n t_ h as _ re ma in ed _c lo se _ to _ 5 %_ be tw e en_ the_ 19 6 0 s_and_ 20 0 4 ._A_ s imil ar_ pa t te r n_ h as _ been_ ob se r ve d_ in_ E ur op e_ wh ere_ about_ 6 %_of _ all_ health _c are_ ex pe n dit ure_ are_ s pe n t_ on _can c er_ tr e at me n t ._ In _ ad dit ion_ to _ health _c are_ ex pe n dit ure_ and_ f in anc ia l _ to x ic it y, _can c er _caus es _ indi rect _c os t s_in_ the_ for m _of_ pr od u ct iv ity_ los se s_ du e_ to _ s ic k_ d a ys ,_ pe r ma ne n t_ inc ap ac ity_ and_ dis abil ity_ as _ we l l _ as _ pr em at ure_ de at h_ dur ing_ wor kin g _ ag e. _ Cancer _caus es _ also_ co st s_ for _ in for ma l _c ar e. _ In di rect _c os t s_and_ in for ma l _c are_ co st s_are_ typ ical ly _ es tim at ed _ to _ exc e ed _or_ e qu al_ the_ health _c are_ co st s_ of _can c er .

E ff e ct _ on_ div or c e
A_ stu d y_ found_ wom en_ we re _ around_ s ix _ tim es _m ore_ lik ely_ to _ be _ div or c ed _ s o on_ af te r _ a_ diagnos is _ of _can c er _com pa red_ to _m en ._ Ra te _of_ se pa ra tion _ for _can c er - sur vi v ors_ sh ow ed _c or rel ations_ with _ ra c e,_ ag e,_ in co me ,_and_ co mo r bi dit i es _ in_ a_ stu d y. _ A_ re vie w_ found_ a_s om e wh at_ de cr e as ed _ div or c e_ ra te _ for _m os t_ c anc er_ typ es,_ and_ no te d_ stu d y_ he te ro gen e ity_ and_ meth od ol o g ical _ we a k ne s se s_ for _m any_ studi es _ on_the_ effect s_ of _can c er_ on_ div or c e.

R es ear ch
B e caus e_c anc er_ is _ a_ c l ass_ of_ diseas es,_ it _ is _ un lik ely_ that _ there_ wi l l _ ev er_ be _ a_s ing le _ " cur e_ for _can c er "_ any_ mo re _ than_ there_ wi l l _ be _ a_s ing le _ tr e at me n t_ for _ all_ infect ious_ diseas es._ A ng i ogenes is _ inhibit ors_ we re _ on c e_ in co r rect ly _ thoug h t_ to _ have_ po te n t ia l _ as _ a_ " s il ve r _ bu l le t "_ tr e at me n t_ ap plic ab le _ to _m any_ typ es _ of _can c er ._A ng i ogenes is _ inhibit ors_ and_ ot he r _can c er_ therap e ut ic s_are_ us ed _ in _com bi n ation_ to _ reduc e_cancer _m or bi dit y_and_ mo r ta li t y.
Ex pe r im en ta l _can c er_ tr e at me n t s_are_ studi ed _ in _c li n ical _ tr ia l s_ to _com pa re _ the_ pr op os ed _ tr e at me n t_ to _ the_ be st_ ex is t ing_ tr e at me n t ._T reat me n t s_ that _ su cc e ed ed _ in_ one_ c anc er_ typ e_c an_ be _ te st ed _ again st_ ot he r _ typ es._ Di ag no st ic_ te st s_are_ un de r _ de ve lo p me n t_ to _ be t te r _ ta r get _ the_ r ight_ therap i es _ to _ the_ r ight_ pa t i ent s,_ b as ed _ on_ their_ indi vidu al_ bi ol o g y.
C anc er_ rese ar ch _ f oc us es _ on_the_ fol lo wi ng _ issu es :

A gen t s_( e. g ._ vi r us es )_ and_ ev ent s_( e. g ._ mu ta tion s )_ that _cause_ or_ fac il it ate_ gen etic _ch ang es _ in _cells_ de st in ed _ to _ be co me _can c er .
The_ pr e c is e_ n at ure_ of_the_ gen etic _ dam age_ and_ the_ gen es _ that _ are_ affect ed _ by_ it .
The_ co n sequenc es _of_ those_ gen etic _ch ang es _ on_the_ bi ol o g y_of_ the_c ell ,_ bo th_ in_ gener ating_ the_ def in ing_ pr op er t i es _of_ a_ cancer _cell _and_ in_ fac il it ating_ ad dit ion al_ gen etic _ ev ent s_ that _ lead _ to _ f ur ther_ pr o g ress ion_ of_the_ cancer .
The_ im pr ov ed _ un de r st an di ng _ of _m ol e cul ar_ bi ol o g y_and_ c el lu lar _ bi ol o g y_ du e_ to _can c er_ rese ar ch _ h as _ le d_ to _ ne w_ tr e at me n t s_ for _can c er_ s inc e_ US _ P res id ent_ R ic har d_ N ix on_ dec lar ed _ the_ " w ar_ on _can c er "_ in_ 19 7 1. _ S inc e_ th en ,_ the_ co un tr y_ h as _ s pe n t_ over _ $ 20 0_ bi l li on_ on _can c er_ rese ar ch ,_ inclu di ng _ res ourc es _ fr om _ p u bl ic_ and_ pr iv ate_ se ct or s. _ The_ c anc er_ de at h_ ra te _ ( ad j us t ing_ for _ s iz e_and_ age_ of_the_ po p ul ation )_ dec li ne d_ by_ f ive_ pe r c ent_ be tw e en_ 19 5 0_ and_ 20 0 5 .
C om pe t it ion_ for _ f in anc ia l _ res ourc es _ appe ar s_ to _ have_ sup pr es se d_ the_ cr e ativ it y, _c o op er ation,_ risk - ta kin g _and_ orig inal_ th in kin g _ requ ir ed _ to _m a ke_ f und am en ta l _ disc over i es,_ un du ly _ f av or ing_ low - ris k_ rese ar ch _ in to _ s ma l l _ in cr em en ta l _ advanc em ent s_ over _ risk i er,_ mo re _ in no v ativ e_ rese ar ch ._O ther _con sequenc es _ of _com pe t it ion_ appe ar_ to _ be _m any_ studi es _ with _ dr am at ic _c l a im s_ wh ose_ result s_c an not_ be _ re plic at ed _and_ pe r ve r se _ inc ent iv es _ that _ en co ur age_ g ra n te e_ in st it ut ion s_ to _ gro w_ with out_ ma kin g _ suff ici ent_ in ve st me n t s_in_ their_ ow n_ fac ult y_and_ fac il it i es.
V ir ot he ra p y, _ which_ us es _con ve r t_ vi r us es,_ is _ be ing_ studi ed .
In _ the_ w a ke_ of_the_ C O V I D - 19 _ pa n de mic ,_ there_ h as _ been_ a_ wor r y_ that _can c er_ rese ar ch _and_ tr e at me n t_ are_ s lo wi ng _ do w n .

P re gn anc y
C anc er_ affect s_ ap pr ox im ately_ 1 _ in_ 1 ,00 0_ pr e gn ant_ wom en ._The_ most _com mo n_ c anc ers_ found_ dur ing_ pr e gn anc y_ are_ the_s ame_ as _ the_ most _com mo n_ c anc ers_ found_ in_ no n - pr e gn ant_ wom en_ dur ing _chil d be ar ing_ ag es :_ bre as t_ c anc er,_ c er vi c al _can c er,_ leuk em ia ,_ lymp ho ma ,_ me l an oma,_ ov ar ia n_ c anc er_ and_ co lo rect al _can c er .
Di ag nos ing_ a_ ne w_ c anc er_ in_ a_ pr e gn ant_ wom an_ is _ diff icul t ,_ in_ pa r t_ becaus e_ any_ symp to m s_are_ co m mo n ly _ as su me d_ to _ be _ a_ no r ma l _ disc om for t_ ass oc ia te d_ with _ pr e gn anc y. _ A s_ a_ result ,_ c anc er_ is _ typ ical ly _ disc over ed _ at_ a_s om e wh at_ l at er_ stag e_ than_ av er ag e. _ Some_ im aging_ pr oc ed ur es,_ su ch _ as _ M R I s_( ma gn etic _ res on anc e_ im ag ing ),_ C T _ sc ans ,_ ul tr as oun d s_and_ ma m mo g ra m s_ with _ fe ta l _ sh i el di ng _ are_ co n sid er ed _ s af e_ dur ing_ pr e gn anc y ;_ som e_ ot he r s,_ su ch _ as _ P E T _ sc ans ,_ are_ not .
T reat me n t_ is _ gener al ly _ the_s ame_ as _ for _ no n - pr e gn ant_ wom en ._H ow ever,_ radi ation _and_ radi o ac t ive_ drug s_are_ no r ma l ly _ av o id ed _ dur ing_ pr e gn anc y, _ espec ia l ly _ if_ the_ fe ta l _ do se _m ight_ exc e ed _ 10 0_ c G y. _ In _ som e_c as es,_ som e_ or_ all_ tr e at me n t s_are_ po st po ne d_ un t il _ af te r _ bi r th_ if_ the_c anc er_ is _ diag no se d_ l ate_ in_the_ pr e gn anc y. _ E ar ly _ de li ve r i es _ are_ of te n_ us ed _ to _ advanc e_the_ st ar t_of_ tr e at me n t ._S ur ger y_ is _ gener al ly _ s af e,_ but_ pe l vi c _ surger i es _ dur ing_the_ fir st_ tr im es te r _m a y_ caus e_ mis c arr ia g e. _ Some_ tr e at me n t s,_ espec ia l ly _certa in _c he mo therapy_ drug s_ g iv en_ dur ing_the_ fir st_ tr im es te r ,_ in cr e as e_the_ ris k_ of_ bi r th_ defect s_and_ pr e gn anc y_ los s_( s po n ta ne ous_ ab or tion s_and_ st ill bi r th s ) .
E le ctive_ ab or tion s_are_ not_ requ ir ed _ and ,_ for _ the_ most _com mo n_ for m s_and_ stag es _ of _can c er,_ do _ not_ im pr ov e_the_ mo ther 's_ sur vi v al ._ In _ a_ fe w_ in stanc es,_ su ch _ as _ advanc ed _ ut er ine_ c anc er,_ the_ pr e gn anc y_ c an not_ be _con t in u ed _and_ in_ ot he r s,_ the_ pa t i ent_ may_ end_ the_ pr e gn anc y_ s o_ that _ sh e_c an_ be g in_ ag g ress ive_ ch em ot he ra p y.
Some_ tr e at me n t s_c an_ in te r fe re _ with _ the_ mo ther 's_ abil ity_ to _ g ive_ bi r th_ v ag in al ly _or_ to _ bre as t fe ed ._C er vi c al _can c er _m a y_ requ ir e_ bi r th_ by_ C a es ar e an_ se ct ion ._ Radiation_ to _ the_ bre as t_ reduc es _ the_ abil ity_ of_ that _ bre as t_ to _ pr od u c e_ m il k_ and_ in cr e as es _ the_ ris k_ of _m as t it is ._A l s o ,_wh en _c he mo therapy_ is _ g iv en_ af te r _ bi r th ,_ ma n y_of_ the_ drug s_ appe ar_ in_ bre as t_ m il k ,_wh ic h_ co ul d_ har m _ the_b ab y.

O ther_ anim als
V et er in ary_ on co lo g y, _conc en tr at ing _m ain ly _ on _c at s_and_ do g s,_ is _ a_ gro wi ng _ spec ia l t y_ in_ we al th y_ co un tr i es _and_ the_ maj or_ for m s_of_ hum an_ tr e at me n t_ su ch _ as _ surger y_and_ radi ot he ra p y_ may_ be _ of fe re d ._The_ most _com mo n_ typ es _ of _can c er_ diff er,_ but_ the_c anc er_ bu r de n_ se em s_ at_ le as t_ as _ high_ in_ pe t s_ as _ in_ hum an s. _ A n im als ,_ typ ical ly _ ro de n t s,_ are_ of te n_ us ed _ in _can c er_ rese ar ch _and_ studi es _of_ n at ur al _can c ers_ in_ lar ger _ anim al s_ may_ be ne f it _ rese ar ch _ in to _ hum an _can c er .
A cr os s_ wi ld_ anim als ,_ there_ is _ st ill_ li m it ed _ d at a_ on _can c er ._ N on et he le s s,_ a_ stu d y_ p u bl is he d_ in_ 20 2 2 ,_ ex pl or ed _can c er_ ris k_ in_ ( no n - do me st ic at ed )_ z o o_ ma m ma l s,_ be lo ng ing_ to _ 19 1 _ spec i es,_ 1 10 , 1 4 8 _ indi vidu al ,_ de mo n st ra te d_ that _can c er_ is _ a_ u bi qu it ous_ disease_ of _m am ma l s_and_ it _can _ em erg e_ an y wh ere_ al ong_ the_ ma m ma li an_ ph yl ogen y. _ Th is _ rese ar ch _ also_ high li g h te d_ that _can c er_ ris k_ is _ not_ un if orm ly _ di str ibut ed _ al ong _m am ma l s. _ F or_ in stanc e,_ spec i es _ in_the_ or de r _ C ar n iv or a_ are_ pa r t icul ar ly _ pr one_ to _ be _ affect ed _ by_ c anc er_ ( e. g ._ over _ 2 5 %_of _c lo u de d_ le op ar d s,_ b at - ear ed _ f ox es _and_ red_ w ol ve s_ di e_ of _can c er ),_ wh ile_ un g ul at es _ ( espec ia l ly _ ev en - to ed _ un g ul at es )_ appe ar_ to _ fac e_ co n s is te n t ly _ lo w_ c anc er_ risk s.
In _ no n - hum ans ,_ a_ fe w_ typ es _of_ transmis sib le _can c er_ have_ also_ been_ de sc r ib ed ,_wh ere in_the_ c anc er_ s pr e ad s_ be tw e en_ anim al s_ by_ transmis s ion_ of_the_ tumor _cells_ th em se l ve s. _ Th is _ ph en om en on_ is _ se en_ in_ do g s_ with _ St ic k er 's_ s ar co ma _ ( also_ known_ as _can ine_ transmis sib le _ ve ne re al_ tumor ),_ and_ in_ T as ma n ia n_ de vi l s_ with _ de vi l _ fac ia l _ tum our _ disease_ ( D F T D ) .

S e e_ als o
C anc er_ screen ing
C anc er_ tr e at me n t
C aus es _ of _can c er
Ep id emi ol o g y_ of _can c er
O cc up ation al _can c er
O n co lo g y
Met ab ol ic_ the or y_ of _can c er

R ef er enc es
F ur ther_ re ad ing
Ex te r n al_ li n k s

I A R C _ P u bl ic ation s_( W H O )_ | _ P u bl ic ation s. ia r c . fr
" O n_ te l li ng _can c er_ pa t i ent s_ to _ have_ a_ po sit ive_ att it u de "_ at_ The_ A t l ant ic
W H O _ fac t_ sh e et _ on _can c er
N ational_ F ir ef igh te r _ R e g is tr y_ ( N F R )_ for _ C anc er,_ N ational_ In st it ut e_ for _ O cc up ational_ S af et y_and_ H e al th_ ( N I O S H ),_ US A
St op _carcin ogen s_ at_ wor k ,_ E U _ O S H A ._The_ sit e_ sh ar es _ in for ma tion _ to _ he l p _ pr ev ent_ wor k ers_ fr om _ be ing_ expo se d_ to _carcin ogen s_in_ the_ wor k pl ac e.
O cc up ational_ C anc er,_ N I O S H .
N I O S H _ P oc k et _ g u ide_ to _c he mic al_ h a z ar d s,_ A p pe n di x _ A - _ N I O S H _ P ot ent ia l _ O cc up ational_ C arcin ogen s.
